WO2012023030A2 - Vacuum avoiding packaging systems and methods thereof - Google Patents
Vacuum avoiding packaging systems and methods thereof Download PDFInfo
- Publication number
- WO2012023030A2 WO2012023030A2 PCT/IB2011/001901 IB2011001901W WO2012023030A2 WO 2012023030 A2 WO2012023030 A2 WO 2012023030A2 IB 2011001901 W IB2011001901 W IB 2011001901W WO 2012023030 A2 WO2012023030 A2 WO 2012023030A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- gas
- packaging system
- releasing material
- gas releasing
- product
- Prior art date
Links
- 238000004806 packaging method and process Methods 0.000 title claims abstract description 85
- 238000000034 method Methods 0.000 title claims description 46
- 239000000463 material Substances 0.000 claims abstract description 179
- 230000015556 catabolic process Effects 0.000 claims abstract description 16
- 238000006731 degradation reaction Methods 0.000 claims abstract description 16
- 239000007789 gas Substances 0.000 claims description 237
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 31
- 239000001301 oxygen Substances 0.000 claims description 31
- 229910052760 oxygen Inorganic materials 0.000 claims description 31
- 239000002516 radical scavenger Substances 0.000 claims description 25
- 229940123973 Oxygen scavenger Drugs 0.000 claims description 24
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 21
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 18
- 230000004913 activation Effects 0.000 claims description 15
- 239000000126 substance Substances 0.000 claims description 15
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 13
- 239000003463 adsorbent Substances 0.000 claims description 12
- 150000004676 glycans Chemical class 0.000 claims description 11
- 229920001282 polysaccharide Polymers 0.000 claims description 11
- 239000005017 polysaccharide Substances 0.000 claims description 11
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 10
- 230000006698 induction Effects 0.000 claims description 10
- 229910052757 nitrogen Inorganic materials 0.000 claims description 10
- 230000005855 radiation Effects 0.000 claims description 10
- 150000001720 carbohydrates Chemical class 0.000 claims description 9
- 239000001569 carbon dioxide Substances 0.000 claims description 9
- 150000003839 salts Chemical class 0.000 claims description 9
- 230000008859 change Effects 0.000 claims description 8
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 claims description 8
- XYYVYLMBEZUESM-UHFFFAOYSA-N dihydrocodeine Natural products C1C(N(CCC234)C)C2C=CC(=O)C3OC2=C4C1=CC=C2OC XYYVYLMBEZUESM-UHFFFAOYSA-N 0.000 claims description 8
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 claims description 8
- 239000011261 inert gas Substances 0.000 claims description 8
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 claims description 8
- 229910052742 iron Inorganic materials 0.000 claims description 7
- 229910052751 metal Inorganic materials 0.000 claims description 7
- 239000002184 metal Substances 0.000 claims description 7
- BRUQQQPBMZOVGD-XFKAJCMBSA-N Oxycodone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(OC)C2=C5[C@@]13CCN4C BRUQQQPBMZOVGD-XFKAJCMBSA-N 0.000 claims description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 6
- 229920002472 Starch Polymers 0.000 claims description 6
- 239000002274 desiccant Substances 0.000 claims description 6
- 229960002085 oxycodone Drugs 0.000 claims description 6
- 239000004033 plastic Substances 0.000 claims description 6
- 229920003023 plastic Polymers 0.000 claims description 6
- 238000007789 sealing Methods 0.000 claims description 6
- 235000019698 starch Nutrition 0.000 claims description 6
- 230000005670 electromagnetic radiation Effects 0.000 claims description 5
- 239000012530 fluid Substances 0.000 claims description 5
- 230000003647 oxidation Effects 0.000 claims description 5
- 238000007254 oxidation reaction Methods 0.000 claims description 5
- TVYLLZQTGLZFBW-ZBFHGGJFSA-N (R,R)-tramadol Chemical compound COC1=CC=CC([C@]2(O)[C@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-ZBFHGGJFSA-N 0.000 claims description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 4
- IJVCSMSMFSCRME-KBQPJGBKSA-N Dihydromorphine Chemical compound O([C@H]1[C@H](CC[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O IJVCSMSMFSCRME-KBQPJGBKSA-N 0.000 claims description 4
- UQCNKQCJZOAFTQ-ISWURRPUSA-N Oxymorphone Chemical compound O([C@H]1C(CC[C@]23O)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O UQCNKQCJZOAFTQ-ISWURRPUSA-N 0.000 claims description 4
- 235000014633 carbohydrates Nutrition 0.000 claims description 4
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 claims description 4
- 229960004126 codeine Drugs 0.000 claims description 4
- 230000003247 decreasing effect Effects 0.000 claims description 4
- RBOXVHNMENFORY-DNJOTXNNSA-N dihydrocodeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC RBOXVHNMENFORY-DNJOTXNNSA-N 0.000 claims description 4
- 229960000920 dihydrocodeine Drugs 0.000 claims description 4
- LLPOLZWFYMWNKH-CMKMFDCUSA-N hydrocodone Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)CC(=O)[C@@H]1OC1=C2C3=CC=C1OC LLPOLZWFYMWNKH-CMKMFDCUSA-N 0.000 claims description 4
- 229960000240 hydrocodone Drugs 0.000 claims description 4
- WVLOADHCBXTIJK-YNHQPCIGSA-N hydromorphone Chemical compound O([C@H]1C(CC[C@H]23)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O WVLOADHCBXTIJK-YNHQPCIGSA-N 0.000 claims description 4
- 229960001410 hydromorphone Drugs 0.000 claims description 4
- 229960005181 morphine Drugs 0.000 claims description 4
- 229960005118 oxymorphone Drugs 0.000 claims description 4
- 150000005846 sugar alcohols Chemical class 0.000 claims description 4
- 229960004380 tramadol Drugs 0.000 claims description 4
- TVYLLZQTGLZFBW-GOEBONIOSA-N tramadol Natural products COC1=CC=CC([C@@]2(O)[C@@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-GOEBONIOSA-N 0.000 claims description 4
- LLPOLZWFYMWNKH-UHFFFAOYSA-N trans-dihydrocodeinone Natural products C1C(N(CCC234)C)C2CCC(=O)C3OC2=C4C1=CC=C2OC LLPOLZWFYMWNKH-UHFFFAOYSA-N 0.000 claims description 4
- 229920001353 Dextrin Polymers 0.000 claims description 3
- 239000004375 Dextrin Substances 0.000 claims description 3
- 108010010803 Gelatin Proteins 0.000 claims description 3
- 239000003570 air Substances 0.000 claims description 3
- 238000004891 communication Methods 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- 150000002016 disaccharides Chemical class 0.000 claims description 3
- 239000008273 gelatin Substances 0.000 claims description 3
- 229920000159 gelatin Polymers 0.000 claims description 3
- 235000019322 gelatine Nutrition 0.000 claims description 3
- 235000011852 gelatine desserts Nutrition 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 230000005291 magnetic effect Effects 0.000 claims description 3
- 238000002844 melting Methods 0.000 claims description 3
- 230000008018 melting Effects 0.000 claims description 3
- 150000002772 monosaccharides Chemical class 0.000 claims description 3
- 229920001542 oligosaccharide Polymers 0.000 claims description 3
- 150000002482 oligosaccharides Chemical class 0.000 claims description 3
- 230000001590 oxidative effect Effects 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- 239000000377 silicon dioxide Substances 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 239000008107 starch Substances 0.000 claims description 3
- 229920001817 Agar Polymers 0.000 claims description 2
- 229920001661 Chitosan Polymers 0.000 claims description 2
- 102000004190 Enzymes Human genes 0.000 claims description 2
- 108090000790 Enzymes Proteins 0.000 claims description 2
- 239000004952 Polyamide Substances 0.000 claims description 2
- 229910021536 Zeolite Inorganic materials 0.000 claims description 2
- 235000010419 agar Nutrition 0.000 claims description 2
- 239000008272 agar Substances 0.000 claims description 2
- 235000010443 alginic acid Nutrition 0.000 claims description 2
- 229920000615 alginic acid Polymers 0.000 claims description 2
- 235000010323 ascorbic acid Nutrition 0.000 claims description 2
- 239000011668 ascorbic acid Substances 0.000 claims description 2
- 229960005070 ascorbic acid Drugs 0.000 claims description 2
- 229920001525 carrageenan Polymers 0.000 claims description 2
- 235000010418 carrageenan Nutrition 0.000 claims description 2
- 239000003610 charcoal Substances 0.000 claims description 2
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 claims description 2
- 239000004744 fabric Substances 0.000 claims description 2
- 239000000123 paper Substances 0.000 claims description 2
- 239000001814 pectin Substances 0.000 claims description 2
- 229920001277 pectin Polymers 0.000 claims description 2
- 235000010987 pectin Nutrition 0.000 claims description 2
- 229920002647 polyamide Polymers 0.000 claims description 2
- 229930195735 unsaturated hydrocarbon Natural products 0.000 claims description 2
- 229920001285 xanthan gum Polymers 0.000 claims description 2
- 239000010457 zeolite Substances 0.000 claims description 2
- 239000000014 opioid analgesic Substances 0.000 claims 6
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims 1
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 claims 1
- 240000008886 Ceratonia siliqua Species 0.000 claims 1
- 235000013912 Ceratonia siliqua Nutrition 0.000 claims 1
- 244000303965 Cyamopsis psoralioides Species 0.000 claims 1
- 229940023476 agar Drugs 0.000 claims 1
- 229940072056 alginate Drugs 0.000 claims 1
- 239000000679 carrageenan Substances 0.000 claims 1
- 229940113118 carrageenan Drugs 0.000 claims 1
- 229960000292 pectin Drugs 0.000 claims 1
- 230000000007 visual effect Effects 0.000 claims 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims 1
- 238000009826 distribution Methods 0.000 description 13
- 229940079593 drug Drugs 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 239000011159 matrix material Substances 0.000 description 9
- 239000003814 drug Substances 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- -1 diamorphone Chemical compound 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 238000010525 oxidative degradation reaction Methods 0.000 description 7
- 239000013543 active substance Substances 0.000 description 6
- 239000003317 industrial substance Substances 0.000 description 6
- 235000002639 sodium chloride Nutrition 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 4
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 4
- 238000003801 milling Methods 0.000 description 4
- WVYADZUPLLSGPU-UHFFFAOYSA-N salsalate Chemical compound OC(=O)C1=CC=CC=C1OC(=O)C1=CC=CC=C1O WVYADZUPLLSGPU-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000008186 active pharmaceutical agent Substances 0.000 description 3
- 239000000730 antalgic agent Substances 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 239000011888 foil Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 229940121367 non-opioid analgesics Drugs 0.000 description 3
- 239000000825 pharmaceutical preparation Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 230000002000 scavenging effect Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- SBDNJUWAMKYJOX-UHFFFAOYSA-N Meclofenamic Acid Chemical compound CC1=CC=C(Cl)C(NC=2C(=CC=CC=2)C(O)=O)=C1Cl SBDNJUWAMKYJOX-UHFFFAOYSA-N 0.000 description 2
- 229920000881 Modified starch Polymers 0.000 description 2
- DEXMFYZAHXMZNM-UHFFFAOYSA-N Narceine Chemical compound OC(=O)C1=C(OC)C(OC)=CC=C1C(=O)CC1=C(CCN(C)C)C=C(OCO2)C2=C1OC DEXMFYZAHXMZNM-UHFFFAOYSA-N 0.000 description 2
- MITFXPHMIHQXPI-UHFFFAOYSA-N Oraflex Chemical compound N=1C2=CC(C(C(O)=O)C)=CC=C2OC=1C1=CC=C(Cl)C=C1 MITFXPHMIHQXPI-UHFFFAOYSA-N 0.000 description 2
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 229960001138 acetylsalicylic acid Drugs 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 235000013351 cheese Nutrition 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000012611 container material Substances 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 229960001259 diclofenac Drugs 0.000 description 2
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 2
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 229920001903 high density polyethylene Polymers 0.000 description 2
- 239000004700 high-density polyethylene Substances 0.000 description 2
- 229960000905 indomethacin Drugs 0.000 description 2
- 238000001746 injection moulding Methods 0.000 description 2
- 235000015110 jellies Nutrition 0.000 description 2
- 239000008274 jelly Substances 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- YIXJRHPUWRPCBB-UHFFFAOYSA-N magnesium nitrate Chemical compound [Mg+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O YIXJRHPUWRPCBB-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229960003803 meclofenamic acid Drugs 0.000 description 2
- 229960003464 mefenamic acid Drugs 0.000 description 2
- HYYBABOKPJLUIN-UHFFFAOYSA-N mefenamic acid Chemical compound CC1=CC=CC(NC=2C(=CC=CC=2)C(O)=O)=C1C HYYBABOKPJLUIN-UHFFFAOYSA-N 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 2
- 125000004430 oxygen atom Chemical group O* 0.000 description 2
- 238000012858 packaging process Methods 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 235000021400 peanut butter Nutrition 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 229940127557 pharmaceutical product Drugs 0.000 description 2
- CPJSUEIXXCENMM-UHFFFAOYSA-N phenacetin Chemical compound CCOC1=CC=C(NC(C)=O)C=C1 CPJSUEIXXCENMM-UHFFFAOYSA-N 0.000 description 2
- 229960002702 piroxicam Drugs 0.000 description 2
- QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 229960000953 salsalate Drugs 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 235000015067 sauces Nutrition 0.000 description 2
- 238000007873 sieving Methods 0.000 description 2
- 235000011888 snacks Nutrition 0.000 description 2
- 235000011121 sodium hydroxide Nutrition 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 239000002594 sorbent Substances 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 229960000894 sulindac Drugs 0.000 description 2
- MLKXDPUZXIRXEP-MFOYZWKCSA-N sulindac Chemical compound CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(S(C)=O)C=C1 MLKXDPUZXIRXEP-MFOYZWKCSA-N 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000013077 target material Substances 0.000 description 2
- 229960001017 tolmetin Drugs 0.000 description 2
- UPSPUYADGBWSHF-UHFFFAOYSA-N tolmetin Chemical compound C1=CC(C)=CC=C1C(=O)C1=CC=C(CC(O)=O)N1C UPSPUYADGBWSHF-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- UVITTYOJFDLOGI-UHFFFAOYSA-N (1,2,5-trimethyl-4-phenylpiperidin-4-yl) propanoate Chemical compound C=1C=CC=CC=1C1(OC(=O)CC)CC(C)N(C)CC1C UVITTYOJFDLOGI-UHFFFAOYSA-N 0.000 description 1
- RJMIEHBSYVWVIN-LLVKDONJSA-N (2r)-2-[4-(3-oxo-1h-isoindol-2-yl)phenyl]propanoic acid Chemical compound C1=CC([C@H](C(O)=O)C)=CC=C1N1C(=O)C2=CC=CC=C2C1 RJMIEHBSYVWVIN-LLVKDONJSA-N 0.000 description 1
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 1
- RDJGLLICXDHJDY-NSHDSACASA-N (2s)-2-(3-phenoxyphenyl)propanoic acid Chemical compound OC(=O)[C@@H](C)C1=CC=CC(OC=2C=CC=CC=2)=C1 RDJGLLICXDHJDY-NSHDSACASA-N 0.000 description 1
- GUHPRPJDBZHYCJ-SECBINFHSA-N (2s)-2-(5-benzoylthiophen-2-yl)propanoic acid Chemical compound S1C([C@H](C(O)=O)C)=CC=C1C(=O)C1=CC=CC=C1 GUHPRPJDBZHYCJ-SECBINFHSA-N 0.000 description 1
- MDKGKXOCJGEUJW-VIFPVBQESA-N (2s)-2-[4-(thiophene-2-carbonyl)phenyl]propanoic acid Chemical compound C1=CC([C@@H](C(O)=O)C)=CC=C1C(=O)C1=CC=CS1 MDKGKXOCJGEUJW-VIFPVBQESA-N 0.000 description 1
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- KLIVRBFRQSOGQI-UHFFFAOYSA-N 2-(11-oxo-6h-benzo[c][1]benzothiepin-3-yl)acetic acid Chemical compound S1CC2=CC=CC=C2C(=O)C2=CC=C(CC(=O)O)C=C12 KLIVRBFRQSOGQI-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- DCXHLPGLBYHNMU-UHFFFAOYSA-N 2-[1-(4-azidobenzoyl)-5-methoxy-2-methylindol-3-yl]acetic acid Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(N=[N+]=[N-])C=C1 DCXHLPGLBYHNMU-UHFFFAOYSA-N 0.000 description 1
- TYCOFFBAZNSQOJ-UHFFFAOYSA-N 2-[4-(3-fluorophenyl)phenyl]propanoic acid Chemical compound C1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC(F)=C1 TYCOFFBAZNSQOJ-UHFFFAOYSA-N 0.000 description 1
- JIEKMACRVQTPRC-UHFFFAOYSA-N 2-[4-(4-chlorophenyl)-2-phenyl-5-thiazolyl]acetic acid Chemical compound OC(=O)CC=1SC(C=2C=CC=CC=2)=NC=1C1=CC=C(Cl)C=C1 JIEKMACRVQTPRC-UHFFFAOYSA-N 0.000 description 1
- XKSAJZSJKURQRX-UHFFFAOYSA-N 2-acetyloxy-5-(4-fluorophenyl)benzoic acid Chemical compound C1=C(C(O)=O)C(OC(=O)C)=CC=C1C1=CC=C(F)C=C1 XKSAJZSJKURQRX-UHFFFAOYSA-N 0.000 description 1
- JHWIEAWILPSRMU-UHFFFAOYSA-N 2-methyl-3-pyrimidin-4-ylpropanoic acid Chemical compound OC(=O)C(C)CC1=CC=NC=N1 JHWIEAWILPSRMU-UHFFFAOYSA-N 0.000 description 1
- IYNWSQDZXMGGGI-NUEKZKHPSA-N 3-hydroxymorphinan Chemical compound C1CCC[C@H]2[C@H]3CC4=CC=C(O)C=C4[C@]21CCN3 IYNWSQDZXMGGGI-NUEKZKHPSA-N 0.000 description 1
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 1
- SYCHUQUJURZQMO-UHFFFAOYSA-N 4-hydroxy-2-methyl-1,1-dioxo-n-(1,3-thiazol-2-yl)-1$l^{6},2-benzothiazine-3-carboxamide Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=NC=CS1 SYCHUQUJURZQMO-UHFFFAOYSA-N 0.000 description 1
- USSIQXCVUWKGNF-UHFFFAOYSA-N 6-(dimethylamino)-4,4-diphenylheptan-3-one Chemical compound C=1C=CC=CC=1C(CC(C)N(C)C)(C(=O)CC)C1=CC=CC=C1 USSIQXCVUWKGNF-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 229920001685 Amylomaize Polymers 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 244000056139 Brassica cretica Species 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- 101100492805 Caenorhabditis elegans atm-1 gene Proteins 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 244000241235 Citrullus lanatus Species 0.000 description 1
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 1
- OIRAEJWYWSAQNG-UHFFFAOYSA-N Clidanac Chemical compound ClC=1C=C2C(C(=O)O)CCC2=CC=1C1CCCCC1 OIRAEJWYWSAQNG-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- YTBSYETUWUMLBZ-UHFFFAOYSA-N D-Erythrose Natural products OCC(O)C(O)C=O YTBSYETUWUMLBZ-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- WQZGKKKJIJFFOK-CBPJZXOFSA-N D-Gulose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O WQZGKKKJIJFFOK-CBPJZXOFSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- WQZGKKKJIJFFOK-WHZQZERISA-N D-aldose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-WHZQZERISA-N 0.000 description 1
- WQZGKKKJIJFFOK-IVMDWMLBSA-N D-allopyranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-IVMDWMLBSA-N 0.000 description 1
- LKDRXBCSQODPBY-JDJSBBGDSA-N D-allulose Chemical compound OCC1(O)OC[C@@H](O)[C@@H](O)[C@H]1O LKDRXBCSQODPBY-JDJSBBGDSA-N 0.000 description 1
- YTBSYETUWUMLBZ-IUYQGCFVSA-N D-erythrose Chemical compound OC[C@@H](O)[C@@H](O)C=O YTBSYETUWUMLBZ-IUYQGCFVSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- MNQZXJOMYWMBOU-VKHMYHEASA-N D-glyceraldehyde Chemical compound OC[C@@H](O)C=O MNQZXJOMYWMBOU-VKHMYHEASA-N 0.000 description 1
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-NQXXGFSBSA-N D-ribulose Chemical compound OC[C@@H](O)[C@@H](O)C(=O)CO ZAQJHHRNXZUBTE-NQXXGFSBSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-UHFFFAOYSA-N D-threo-2-Pentulose Natural products OCC(O)C(O)C(=O)CO ZAQJHHRNXZUBTE-UHFFFAOYSA-N 0.000 description 1
- YTBSYETUWUMLBZ-QWWZWVQMSA-N D-threose Chemical compound OC[C@@H](O)[C@H](O)C=O YTBSYETUWUMLBZ-QWWZWVQMSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-WUJLRWPWSA-N D-xylulose Chemical compound OC[C@@H](O)[C@H](O)C(=O)CO ZAQJHHRNXZUBTE-WUJLRWPWSA-N 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 206010056474 Erythrosis Diseases 0.000 description 1
- OGDVEMNWJVYAJL-LEPYJNQMSA-N Ethyl morphine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OCC OGDVEMNWJVYAJL-LEPYJNQMSA-N 0.000 description 1
- OGDVEMNWJVYAJL-UHFFFAOYSA-N Ethylmorphine Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OCC OGDVEMNWJVYAJL-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
- 229920000926 Galactomannan Polymers 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- GVGLGOZIDCSQPN-PVHGPHFFSA-N Heroin Chemical compound O([C@H]1[C@H](C=C[C@H]23)OC(C)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4OC(C)=O GVGLGOZIDCSQPN-PVHGPHFFSA-N 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- UETNIIAIRMUTSM-UHFFFAOYSA-N Jacareubin Natural products CC1(C)OC2=CC3Oc4c(O)c(O)ccc4C(=O)C3C(=C2C=C1)O UETNIIAIRMUTSM-UHFFFAOYSA-N 0.000 description 1
- ALFGKMXHOUSVAD-UHFFFAOYSA-N Ketobemidone Chemical compound C=1C=CC(O)=CC=1C1(C(=O)CC)CCN(C)CC1 ALFGKMXHOUSVAD-UHFFFAOYSA-N 0.000 description 1
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VSOAQEOCSA-N L-altropyranose Chemical compound OC[C@@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-VSOAQEOCSA-N 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- JAQUASYNZVUNQP-USXIJHARSA-N Levorphanol Chemical compound C1C2=CC=C(O)C=C2[C@]23CCN(C)[C@H]1[C@@H]2CCCC3 JAQUASYNZVUNQP-USXIJHARSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 240000002129 Malva sylvestris Species 0.000 description 1
- 235000006770 Malva sylvestris Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- XADCESSVHJOZHK-UHFFFAOYSA-N Meperidine Chemical compound C=1C=CC=CC=1C1(C(=O)OCC)CCN(C)CC1 XADCESSVHJOZHK-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- IDBPHNDTYPBSNI-UHFFFAOYSA-N N-(1-(2-(4-Ethyl-5-oxo-2-tetrazolin-1-yl)ethyl)-4-(methoxymethyl)-4-piperidyl)propionanilide Chemical compound C1CN(CCN2C(N(CC)N=N2)=O)CCC1(COC)N(C(=O)CC)C1=CC=CC=C1 IDBPHNDTYPBSNI-UHFFFAOYSA-N 0.000 description 1
- BLXXJMDCKKHMKV-UHFFFAOYSA-N Nabumetone Chemical compound C1=C(CCC(C)=O)C=CC2=CC(OC)=CC=C21 BLXXJMDCKKHMKV-UHFFFAOYSA-N 0.000 description 1
- UIQMVEYFGZJHCZ-SSTWWWIQSA-N Nalorphine Chemical compound C([C@@H](N(CC1)CC=C)[C@@H]2C=C[C@@H]3O)C4=CC=C(O)C5=C4[C@@]21[C@H]3O5 UIQMVEYFGZJHCZ-SSTWWWIQSA-N 0.000 description 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
- JZFPYUNJRRFVQU-UHFFFAOYSA-N Niflumic acid Chemical compound OC(=O)C1=CC=CN=C1NC1=CC=CC(C(F)(F)F)=C1 JZFPYUNJRRFVQU-UHFFFAOYSA-N 0.000 description 1
- ONBWJWYUHXVEJS-ZTYRTETDSA-N Normorphine Chemical compound C([C@@H](NCC1)[C@@H]2C=C[C@@H]3O)C4=CC=C(O)C5=C4[C@@]21[C@H]3O5 ONBWJWYUHXVEJS-ZTYRTETDSA-N 0.000 description 1
- 229940127450 Opioid Agonists Drugs 0.000 description 1
- 239000008896 Opium Substances 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 244000134552 Plantago ovata Species 0.000 description 1
- 235000003421 Plantago ovata Nutrition 0.000 description 1
- 229920001100 Polydextrose Polymers 0.000 description 1
- 239000009223 Psyllium Substances 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 229920000294 Resistant starch Polymers 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 1
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 229960004892 acemetacin Drugs 0.000 description 1
- FSQKKOOTNAMONP-UHFFFAOYSA-N acemetacin Chemical compound CC1=C(CC(=O)OCC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 FSQKKOOTNAMONP-UHFFFAOYSA-N 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- PDODBKYPSUYQGT-UHFFFAOYSA-N acetic acid;1h-indene Chemical class CC(O)=O.C1=CC=C2CC=CC2=C1 PDODBKYPSUYQGT-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229960001391 alfentanil Drugs 0.000 description 1
- KGYFOSCXVAXULR-UHFFFAOYSA-N allylprodine Chemical compound C=1C=CC=CC=1C1(OC(=O)CC)CCN(C)CC1CC=C KGYFOSCXVAXULR-UHFFFAOYSA-N 0.000 description 1
- 229950004361 allylprodine Drugs 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- SRBFZHDQGSBBOR-STGXQOJASA-N alpha-D-lyxopyranose Chemical compound O[C@@H]1CO[C@H](O)[C@@H](O)[C@H]1O SRBFZHDQGSBBOR-STGXQOJASA-N 0.000 description 1
- 229960001349 alphaprodine Drugs 0.000 description 1
- UVAZQQHAVMNMHE-XJKSGUPXSA-N alphaprodine Chemical compound C=1C=CC=CC=1[C@@]1(OC(=O)CC)CCN(C)C[C@@H]1C UVAZQQHAVMNMHE-XJKSGUPXSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 239000001166 ammonium sulphate Substances 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- LKYQLAWMNBFNJT-UHFFFAOYSA-N anileridine Chemical compound C1CC(C(=O)OCC)(C=2C=CC=CC=2)CCN1CCC1=CC=C(N)C=C1 LKYQLAWMNBFNJT-UHFFFAOYSA-N 0.000 description 1
- 229960002512 anileridine Drugs 0.000 description 1
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical class NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 229940111136 antiinflammatory and antirheumatic drug fenamates Drugs 0.000 description 1
- 229940111133 antiinflammatory and antirheumatic drug oxicams Drugs 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 235000015173 baked goods and baking mixes Nutrition 0.000 description 1
- 235000021168 barbecue Nutrition 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 229960005430 benoxaprofen Drugs 0.000 description 1
- RDJGWRFTDZZXSM-RNWLQCGYSA-N benzylmorphine Chemical compound O([C@@H]1[C@]23CCN([C@H](C4)[C@@H]3C=C[C@@H]1O)C)C1=C2C4=CC=C1OCC1=CC=CC=C1 RDJGWRFTDZZXSM-RNWLQCGYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- FLKWNFFCSSJANB-UHFFFAOYSA-N bezitramide Chemical compound O=C1N(C(=O)CC)C2=CC=CC=C2N1C(CC1)CCN1CCC(C#N)(C=1C=CC=CC=1)C1=CC=CC=C1 FLKWNFFCSSJANB-UHFFFAOYSA-N 0.000 description 1
- 229960004611 bezitramide Drugs 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000015496 breakfast cereal Nutrition 0.000 description 1
- 229950005608 bucloxic acid Drugs 0.000 description 1
- IJTPQQVCKPZIMV-UHFFFAOYSA-N bucloxic acid Chemical compound ClC1=CC(C(=O)CCC(=O)O)=CC=C1C1CCCCC1 IJTPQQVCKPZIMV-UHFFFAOYSA-N 0.000 description 1
- RMRJXGBAOAMLHD-IHFGGWKQSA-N buprenorphine Chemical compound C([C@]12[C@H]3OC=4C(O)=CC=C(C2=4)C[C@@H]2[C@]11CC[C@]3([C@H](C1)[C@](C)(O)C(C)(C)C)OC)CN2CC1CC1 RMRJXGBAOAMLHD-IHFGGWKQSA-N 0.000 description 1
- 229960001736 buprenorphine Drugs 0.000 description 1
- IFKLAQQSCNILHL-QHAWAJNXSA-N butorphanol Chemical compound N1([C@@H]2CC3=CC=C(C=C3[C@@]3([C@]2(CCCC3)O)CC1)O)CC1CCC1 IFKLAQQSCNILHL-QHAWAJNXSA-N 0.000 description 1
- 229960001113 butorphanol Drugs 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229960003184 carprofen Drugs 0.000 description 1
- IVUMCTKHWDRRMH-UHFFFAOYSA-N carprofen Chemical compound C1=CC(Cl)=C[C]2C3=CC=C(C(C(O)=O)C)C=C3N=C21 IVUMCTKHWDRRMH-UHFFFAOYSA-N 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 229960000590 celecoxib Drugs 0.000 description 1
- RZEKVGVHFLEQIL-UHFFFAOYSA-N celecoxib Chemical compound C1=CC(C)=CC=C1C1=CC(C(F)(F)F)=NN1C1=CC=C(S(N)(=O)=O)C=C1 RZEKVGVHFLEQIL-UHFFFAOYSA-N 0.000 description 1
- FYGDTMLNYKFZSV-ZWSAEMDYSA-N cellotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-ZWSAEMDYSA-N 0.000 description 1
- 239000004464 cereal grain Substances 0.000 description 1
- 229950010886 clidanac Drugs 0.000 description 1
- GPZLDQAEBHTMPG-UHFFFAOYSA-N clonitazene Chemical compound N=1C2=CC([N+]([O-])=O)=CC=C2N(CCN(CC)CC)C=1CC1=CC=C(Cl)C=C1 GPZLDQAEBHTMPG-UHFFFAOYSA-N 0.000 description 1
- 229950001604 clonitazene Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 235000013409 condiments Nutrition 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 235000012495 crackers Nutrition 0.000 description 1
- 238000006356 dehydrogenation reaction Methods 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 229950003851 desomorphine Drugs 0.000 description 1
- LNNWVNGFPYWNQE-GMIGKAJZSA-N desomorphine Chemical compound C1C2=CC=C(O)C3=C2[C@]24CCN(C)[C@H]1[C@@H]2CCC[C@@H]4O3 LNNWVNGFPYWNQE-GMIGKAJZSA-N 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- WDEFBBTXULIOBB-WBVHZDCISA-N dextilidine Chemical compound C=1C=CC=CC=1[C@@]1(C(=O)OCC)CCC=C[C@H]1N(C)C WDEFBBTXULIOBB-WBVHZDCISA-N 0.000 description 1
- 229960003701 dextromoramide Drugs 0.000 description 1
- INUNXTSAACVKJS-OAQYLSRUSA-N dextromoramide Chemical compound C([C@@H](C)C(C(=O)N1CCCC1)(C=1C=CC=CC=1)C=1C=CC=CC=1)N1CCOCC1 INUNXTSAACVKJS-OAQYLSRUSA-N 0.000 description 1
- 229960004193 dextropropoxyphene Drugs 0.000 description 1
- XLMALTXPSGQGBX-GCJKJVERSA-N dextropropoxyphene Chemical compound C([C@](OC(=O)CC)([C@H](C)CN(C)C)C=1C=CC=CC=1)C1=CC=CC=C1 XLMALTXPSGQGBX-GCJKJVERSA-N 0.000 description 1
- 229960003461 dezocine Drugs 0.000 description 1
- VTMVHDZWSFQSQP-VBNZEHGJSA-N dezocine Chemical compound C1CCCC[C@H]2CC3=CC=C(O)C=C3[C@]1(C)[C@H]2N VTMVHDZWSFQSQP-VBNZEHGJSA-N 0.000 description 1
- 229960002069 diamorphine Drugs 0.000 description 1
- RXTHKWVSXOIHJS-UHFFFAOYSA-N diampromide Chemical compound C=1C=CC=CC=1N(C(=O)CC)CC(C)N(C)CCC1=CC=CC=C1 RXTHKWVSXOIHJS-UHFFFAOYSA-N 0.000 description 1
- 229950001059 diampromide Drugs 0.000 description 1
- HUPFGZXOMWLGNK-UHFFFAOYSA-N diflunisal Chemical compound C1=C(O)C(C(=O)O)=CC(C=2C(=CC(F)=CC=2)F)=C1 HUPFGZXOMWLGNK-UHFFFAOYSA-N 0.000 description 1
- 229960000616 diflunisal Drugs 0.000 description 1
- 229940120503 dihydroxyacetone Drugs 0.000 description 1
- RHUWRJWFHUKVED-UHFFFAOYSA-N dimenoxadol Chemical compound C=1C=CC=CC=1C(C(=O)OCCN(C)C)(OCC)C1=CC=CC=C1 RHUWRJWFHUKVED-UHFFFAOYSA-N 0.000 description 1
- 229950011187 dimenoxadol Drugs 0.000 description 1
- QIRAYNIFEOXSPW-UHFFFAOYSA-N dimepheptanol Chemical compound C=1C=CC=CC=1C(CC(C)N(C)C)(C(O)CC)C1=CC=CC=C1 QIRAYNIFEOXSPW-UHFFFAOYSA-N 0.000 description 1
- 229950004655 dimepheptanol Drugs 0.000 description 1
- CANBGVXYBPOLRR-UHFFFAOYSA-N dimethylthiambutene Chemical compound C=1C=CSC=1C(=CC(C)N(C)C)C1=CC=CS1 CANBGVXYBPOLRR-UHFFFAOYSA-N 0.000 description 1
- 229950005563 dimethylthiambutene Drugs 0.000 description 1
- 229950008972 dioxaphetyl butyrate Drugs 0.000 description 1
- LQGIXNQCOXNCRP-UHFFFAOYSA-N dioxaphetyl butyrate Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(C(=O)OCC)CCN1CCOCC1 LQGIXNQCOXNCRP-UHFFFAOYSA-N 0.000 description 1
- SVDHSZFEQYXRDC-UHFFFAOYSA-N dipipanone Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(C(=O)CC)CC(C)N1CCCCC1 SVDHSZFEQYXRDC-UHFFFAOYSA-N 0.000 description 1
- 229960002500 dipipanone Drugs 0.000 description 1
- 235000011869 dried fruits Nutrition 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- ZOWQTJXNFTWSCS-IAQYHMDHSA-N eptazocine Chemical compound C1N(C)CC[C@@]2(C)C3=CC(O)=CC=C3C[C@@H]1C2 ZOWQTJXNFTWSCS-IAQYHMDHSA-N 0.000 description 1
- 229950010920 eptazocine Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- UQPHVQVXLPRNCX-UHFFFAOYSA-N erythrulose Chemical compound OCC(O)C(=O)CO UQPHVQVXLPRNCX-UHFFFAOYSA-N 0.000 description 1
- WGJHHMKQBWSQIY-UHFFFAOYSA-N ethoheptazine Chemical compound C=1C=CC=CC=1C1(C(=O)OCC)CCCN(C)CC1 WGJHHMKQBWSQIY-UHFFFAOYSA-N 0.000 description 1
- 229960000569 ethoheptazine Drugs 0.000 description 1
- MORSAEFGQPDBKM-UHFFFAOYSA-N ethylmethylthiambutene Chemical compound C=1C=CSC=1C(=CC(C)N(C)CC)C1=CC=CS1 MORSAEFGQPDBKM-UHFFFAOYSA-N 0.000 description 1
- 229950006111 ethylmethylthiambutene Drugs 0.000 description 1
- 229960004578 ethylmorphine Drugs 0.000 description 1
- 229960005293 etodolac Drugs 0.000 description 1
- XFBVBWWRPKNWHW-UHFFFAOYSA-N etodolac Chemical compound C1COC(CC)(CC(O)=O)C2=N[C]3C(CC)=CC=CC3=C21 XFBVBWWRPKNWHW-UHFFFAOYSA-N 0.000 description 1
- PXDBZSCGSQSKST-UHFFFAOYSA-N etonitazene Chemical compound C1=CC(OCC)=CC=C1CC1=NC2=CC([N+]([O-])=O)=CC=C2N1CCN(CC)CC PXDBZSCGSQSKST-UHFFFAOYSA-N 0.000 description 1
- 229950004538 etonitazene Drugs 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229960001419 fenoprofen Drugs 0.000 description 1
- 229960002428 fentanyl Drugs 0.000 description 1
- PJMPHNIQZUBGLI-UHFFFAOYSA-N fentanyl Chemical compound C=1C=CC=CC=1N(C(=O)CC)C(CC1)CCN1CCC1=CC=CC=C1 PJMPHNIQZUBGLI-UHFFFAOYSA-N 0.000 description 1
- 229960002679 fentiazac Drugs 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229960004369 flufenamic acid Drugs 0.000 description 1
- LPEPZBJOKDYZAD-UHFFFAOYSA-N flufenamic acid Chemical compound OC(=O)C1=CC=CC=C1NC1=CC=CC(C(F)(F)F)=C1 LPEPZBJOKDYZAD-UHFFFAOYSA-N 0.000 description 1
- 229950007979 flufenisal Drugs 0.000 description 1
- 229950001284 fluprofen Drugs 0.000 description 1
- 229960002390 flurbiprofen Drugs 0.000 description 1
- SYTBZMRGLBWNTM-UHFFFAOYSA-N flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 235000020006 fruit beer Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000019990 fruit wine Nutrition 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- DBTMGCOVALSLOR-AXAHEAMVSA-N galactotriose Natural products OC[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](CO)O[C@@H](O[C@H]3[C@@H](O)[C@H](O)O[C@@H](CO)[C@@H]3O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O DBTMGCOVALSLOR-AXAHEAMVSA-N 0.000 description 1
- 238000010413 gardening Methods 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 230000020169 heat generation Effects 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 238000009474 hot melt extrusion Methods 0.000 description 1
- 235000019692 hotdogs Nutrition 0.000 description 1
- 239000003845 household chemical Substances 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- WTJBNMUWRKPFRS-UHFFFAOYSA-N hydroxypethidine Chemical compound C=1C=CC(O)=CC=1C1(C(=O)OCC)CCN(C)CC1 WTJBNMUWRKPFRS-UHFFFAOYSA-N 0.000 description 1
- 229950008496 hydroxypethidine Drugs 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 150000002453 idose derivatives Chemical class 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 229960004187 indoprofen Drugs 0.000 description 1
- 230000004941 influx Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 229960004903 invert sugar Drugs 0.000 description 1
- IFKPLJWIEQBPGG-UHFFFAOYSA-N isomethadone Chemical compound C=1C=CC=CC=1C(C(C)CN(C)C)(C(=O)CC)C1=CC=CC=C1 IFKPLJWIEQBPGG-UHFFFAOYSA-N 0.000 description 1
- 229950009272 isomethadone Drugs 0.000 description 1
- 229950002252 isoxicam Drugs 0.000 description 1
- YYUAYBYLJSNDCX-UHFFFAOYSA-N isoxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC=1C=C(C)ON=1 YYUAYBYLJSNDCX-UHFFFAOYSA-N 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 235000008960 ketchup Nutrition 0.000 description 1
- BJHIKXHVCXFQLS-PQLUHFTBSA-N keto-D-tagatose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-PQLUHFTBSA-N 0.000 description 1
- 229960003029 ketobemidone Drugs 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- 229960004752 ketorolac Drugs 0.000 description 1
- OZWKMVRBQXNZKK-UHFFFAOYSA-N ketorolac Chemical compound OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1 OZWKMVRBQXNZKK-UHFFFAOYSA-N 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- RCYBMSQOSGJZLO-BGWNEDDSSA-N levophenacylmorphan Chemical compound C([C@]12CCCC[C@H]1[C@H]1CC3=CC=C(C=C32)O)CN1CC(=O)C1=CC=CC=C1 RCYBMSQOSGJZLO-BGWNEDDSSA-N 0.000 description 1
- 229950007939 levophenacylmorphan Drugs 0.000 description 1
- 229960003406 levorphanol Drugs 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 229950010274 lofentanil Drugs 0.000 description 1
- IMYHGORQCPYVBZ-NLFFAJNJSA-N lofentanil Chemical compound CCC(=O)N([C@@]1([C@@H](CN(CCC=2C=CC=CC=2)CC1)C)C(=O)OC)C1=CC=CC=C1 IMYHGORQCPYVBZ-NLFFAJNJSA-N 0.000 description 1
- 229950001846 mabuprofen Drugs 0.000 description 1
- JVGUNCHERKJFCM-UHFFFAOYSA-N mabuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(=O)NCCO)C=C1 JVGUNCHERKJFCM-UHFFFAOYSA-N 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- FZWBNHMXJMCXLU-YRBKNLIBSA-N manninotriose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-YRBKNLIBSA-N 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 239000008268 mayonnaise Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 229960000365 meptazinol Drugs 0.000 description 1
- JLICHNCFTLFZJN-HNNXBMFYSA-N meptazinol Chemical compound C=1C=CC(O)=CC=1[C@@]1(CC)CCCCN(C)C1 JLICHNCFTLFZJN-HNNXBMFYSA-N 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229950009131 metazocine Drugs 0.000 description 1
- YGSVZRIZCHZUHB-COLVAYQJSA-N metazocine Chemical compound C1C2=CC=C(O)C=C2[C@]2(C)CCN(C)[C@@]1([H])[C@@H]2C YGSVZRIZCHZUHB-COLVAYQJSA-N 0.000 description 1
- 229960001797 methadone Drugs 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- NPZXCTIHHUUEEJ-CMKMFDCUSA-N metopon Chemical compound O([C@@]1(C)C(=O)CC[C@@H]23)C4=C5[C@@]13CCN(C)[C@@H]2CC5=CC=C4O NPZXCTIHHUUEEJ-CMKMFDCUSA-N 0.000 description 1
- 229950006080 metopon Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 235000012459 muffins Nutrition 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- GODGZZGKTZQSAL-VXFFQEMOSA-N myrophine Chemical compound C([C@@H]1[C@@H]2C=C[C@@H]([C@@H]3OC4=C5[C@]23CCN1C)OC(=O)CCCCCCCCCCCCC)C5=CC=C4OCC1=CC=CC=C1 GODGZZGKTZQSAL-VXFFQEMOSA-N 0.000 description 1
- 229950007471 myrophine Drugs 0.000 description 1
- 229960004270 nabumetone Drugs 0.000 description 1
- 229960000805 nalbuphine Drugs 0.000 description 1
- NETZHAKZCGBWSS-CEDHKZHLSA-N nalbuphine Chemical compound C([C@]12[C@H]3OC=4C(O)=CC=C(C2=4)C[C@@H]2[C@]1(O)CC[C@@H]3O)CN2CC1CCC1 NETZHAKZCGBWSS-CEDHKZHLSA-N 0.000 description 1
- 229960000938 nalorphine Drugs 0.000 description 1
- 229960002009 naproxen Drugs 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
- HNDXBGYRMHRUFN-CIVUWBIHSA-N nicomorphine Chemical compound O([C@H]1C=C[C@H]2[C@H]3CC=4C5=C(C(=CC=4)OC(=O)C=4C=NC=CC=4)O[C@@H]1[C@]52CCN3C)C(=O)C1=CC=CN=C1 HNDXBGYRMHRUFN-CIVUWBIHSA-N 0.000 description 1
- 229960004300 nicomorphine Drugs 0.000 description 1
- 229960000916 niflumic acid Drugs 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229950011519 norlevorphanol Drugs 0.000 description 1
- WCJFBSYALHQBSK-UHFFFAOYSA-N normethadone Chemical compound C=1C=CC=CC=1C(CCN(C)C)(C(=O)CC)C1=CC=CC=C1 WCJFBSYALHQBSK-UHFFFAOYSA-N 0.000 description 1
- 229960004013 normethadone Drugs 0.000 description 1
- 229950006134 normorphine Drugs 0.000 description 1
- WCDSHELZWCOTMI-UHFFFAOYSA-N norpipanone Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(C(=O)CC)CCN1CCCCC1 WCDSHELZWCOTMI-UHFFFAOYSA-N 0.000 description 1
- 229950007418 norpipanone Drugs 0.000 description 1
- 229940038580 oat bran Drugs 0.000 description 1
- 239000003402 opiate agonist Substances 0.000 description 1
- 229960001027 opium Drugs 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 229960002739 oxaprozin Drugs 0.000 description 1
- OFPXSFXSNFPTHF-UHFFFAOYSA-N oxaprozin Chemical compound O1C(CCC(=O)O)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 OFPXSFXSNFPTHF-UHFFFAOYSA-N 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 230000005298 paramagnetic effect Effects 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 235000014594 pastries Nutrition 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- VOKSWYLNZZRQPF-GDIGMMSISA-N pentazocine Chemical compound C1C2=CC=C(O)C=C2[C@@]2(C)[C@@H](C)[C@@H]1N(CC=C(C)C)CC2 VOKSWYLNZZRQPF-GDIGMMSISA-N 0.000 description 1
- 229960005301 pentazocine Drugs 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229960000482 pethidine Drugs 0.000 description 1
- 229960003893 phenacetin Drugs 0.000 description 1
- 229950004540 phenadoxone Drugs 0.000 description 1
- LOXCOAXRHYDLOW-UHFFFAOYSA-N phenadoxone Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(C(=O)CC)CC(C)N1CCOCC1 LOXCOAXRHYDLOW-UHFFFAOYSA-N 0.000 description 1
- ZQHYKVKNPWDQSL-KNXBSLHKSA-N phenazocine Chemical compound C([C@@]1(C)C2=CC(O)=CC=C2C[C@@H]2[C@@H]1C)CN2CCC1=CC=CC=C1 ZQHYKVKNPWDQSL-KNXBSLHKSA-N 0.000 description 1
- 229960000897 phenazocine Drugs 0.000 description 1
- 229950011496 phenomorphan Drugs 0.000 description 1
- CFBQYWXPZVQQTN-QPTUXGOLSA-N phenomorphan Chemical compound C([C@]12CCCC[C@H]1[C@H]1CC3=CC=C(C=C32)O)CN1CCC1=CC=CC=C1 CFBQYWXPZVQQTN-QPTUXGOLSA-N 0.000 description 1
- 229960004315 phenoperidine Drugs 0.000 description 1
- IPOPQVVNCFQFRK-UHFFFAOYSA-N phenoperidine Chemical compound C1CC(C(=O)OCC)(C=2C=CC=CC=2)CCN1CCC(O)C1=CC=CC=C1 IPOPQVVNCFQFRK-UHFFFAOYSA-N 0.000 description 1
- 229960002895 phenylbutazone Drugs 0.000 description 1
- VYMDGNCVAMGZFE-UHFFFAOYSA-N phenylbutazonum Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 VYMDGNCVAMGZFE-UHFFFAOYSA-N 0.000 description 1
- 229950006445 piminodine Drugs 0.000 description 1
- PXXKIYPSXYFATG-UHFFFAOYSA-N piminodine Chemical compound C1CC(C(=O)OCC)(C=2C=CC=CC=2)CCN1CCCNC1=CC=CC=C1 PXXKIYPSXYFATG-UHFFFAOYSA-N 0.000 description 1
- 229960001286 piritramide Drugs 0.000 description 1
- IHEHEFLXQFOQJO-UHFFFAOYSA-N piritramide Chemical compound C1CC(C(=O)N)(N2CCCCC2)CCN1CCC(C#N)(C=1C=CC=CC=1)C1=CC=CC=C1 IHEHEFLXQFOQJO-UHFFFAOYSA-N 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 235000013856 polydextrose Nutrition 0.000 description 1
- 239000001259 polydextrose Substances 0.000 description 1
- 229940035035 polydextrose Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 1
- 229910052939 potassium sulfate Inorganic materials 0.000 description 1
- 239000001120 potassium sulphate Substances 0.000 description 1
- 235000011151 potassium sulphates Nutrition 0.000 description 1
- 235000013606 potato chips Nutrition 0.000 description 1
- 235000012434 pretzels Nutrition 0.000 description 1
- 229950010387 proheptazine Drugs 0.000 description 1
- ZXWAUWBYASJEOE-UHFFFAOYSA-N proheptazine Chemical compound C=1C=CC=CC=1C1(OC(=O)CC)CCCN(C)CC1C ZXWAUWBYASJEOE-UHFFFAOYSA-N 0.000 description 1
- 229950004345 properidine Drugs 0.000 description 1
- XJKQCILVUHXVIQ-UHFFFAOYSA-N properidine Chemical compound C=1C=CC=CC=1C1(C(=O)OC(C)C)CCN(C)CC1 XJKQCILVUHXVIQ-UHFFFAOYSA-N 0.000 description 1
- 229950003779 propiram Drugs 0.000 description 1
- ZBAFFZBKCMWUHM-UHFFFAOYSA-N propiram Chemical compound C=1C=CC=NC=1N(C(=O)CC)C(C)CN1CCCCC1 ZBAFFZBKCMWUHM-UHFFFAOYSA-N 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 229940070687 psyllium Drugs 0.000 description 1
- CYMJPJKHCSDSRG-UHFFFAOYSA-N pyrazolidine-3,4-dione Chemical class O=C1CNNC1=O CYMJPJKHCSDSRG-UHFFFAOYSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 235000021254 resistant starch Nutrition 0.000 description 1
- 229960000371 rofecoxib Drugs 0.000 description 1
- RZJQGNCSTQAWON-UHFFFAOYSA-N rofecoxib Chemical compound C1=CC(S(=O)(=O)C)=CC=C1C1=C(C=2C=CC=CC=2)C(=O)OC1 RZJQGNCSTQAWON-UHFFFAOYSA-N 0.000 description 1
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 235000012046 side dish Nutrition 0.000 description 1
- 238000005549 size reduction Methods 0.000 description 1
- 235000010378 sodium ascorbate Nutrition 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 229960004025 sodium salicylate Drugs 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 235000013547 stew Nutrition 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229950005175 sudoxicam Drugs 0.000 description 1
- 229960004739 sufentanil Drugs 0.000 description 1
- GGCSSNBKKAUURC-UHFFFAOYSA-N sufentanil Chemical compound C1CN(CCC=2SC=CC=2)CCC1(COC)N(C(=O)CC)C1=CC=CC=C1 GGCSSNBKKAUURC-UHFFFAOYSA-N 0.000 description 1
- 229960001940 sulfasalazine Drugs 0.000 description 1
- NCEXYHBECQHGNR-QZQOTICOSA-N sulfasalazine Chemical compound C1=C(O)C(C(=O)O)=CC(\N=N\C=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-QZQOTICOSA-N 0.000 description 1
- NCEXYHBECQHGNR-UHFFFAOYSA-N sulfasalazine Natural products C1=C(O)C(C(=O)O)=CC(N=NC=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-UHFFFAOYSA-N 0.000 description 1
- 229960004492 suprofen Drugs 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 229960002871 tenoxicam Drugs 0.000 description 1
- WZWYJBNHTWCXIM-UHFFFAOYSA-N tenoxicam Chemical compound O=C1C=2SC=CC=2S(=O)(=O)N(C)C1=C(O)NC1=CC=CC=N1 WZWYJBNHTWCXIM-UHFFFAOYSA-N 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 229960001312 tiaprofenic acid Drugs 0.000 description 1
- 229960001402 tilidine Drugs 0.000 description 1
- 229950002345 tiopinac Drugs 0.000 description 1
- 229960002905 tolfenamic acid Drugs 0.000 description 1
- YEZNLOUZAIOMLT-UHFFFAOYSA-N tolfenamic acid Chemical compound CC1=C(Cl)C=CC=C1NC1=CC=CC=C1C(O)=O YEZNLOUZAIOMLT-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- FQCQGOZEWWPOKI-UHFFFAOYSA-K trisalicylate-choline Chemical compound [Mg+2].C[N+](C)(C)CCO.OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O FQCQGOZEWWPOKI-UHFFFAOYSA-K 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- 229950007802 zidometacin Drugs 0.000 description 1
- 229960003414 zomepirac Drugs 0.000 description 1
- ZXVNMYWKKDOREA-UHFFFAOYSA-N zomepirac Chemical compound C1=C(CC(O)=O)N(C)C(C(=O)C=2C=CC(Cl)=CC=2)=C1C ZXVNMYWKKDOREA-UHFFFAOYSA-N 0.000 description 1
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
- B65D81/18—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents providing specific environment for contents, e.g. temperature above or below ambient
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A23B2/00—Preservation of foods or foodstuffs, in general
- A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
- A23B2/704—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of gases, e.g. fumigation; Compositions or apparatus therefor
- A23B2/708—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of gases, e.g. fumigation; Compositions or apparatus therefor in a controlled atmosphere, e.g. partial vacuum, comprising only CO2, N2, O2 or H2O
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
- B65D81/18—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents providing specific environment for contents, e.g. temperature above or below ambient
- B65D81/20—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents providing specific environment for contents, e.g. temperature above or below ambient under vacuum or superatmospheric pressure, or in a special atmosphere, e.g. of inert gas
- B65D81/2069—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents providing specific environment for contents, e.g. temperature above or below ambient under vacuum or superatmospheric pressure, or in a special atmosphere, e.g. of inert gas in a special atmosphere
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
- B65D81/18—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents providing specific environment for contents, e.g. temperature above or below ambient
- B65D81/20—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents providing specific environment for contents, e.g. temperature above or below ambient under vacuum or superatmospheric pressure, or in a special atmosphere, e.g. of inert gas
- B65D81/2069—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents providing specific environment for contents, e.g. temperature above or below ambient under vacuum or superatmospheric pressure, or in a special atmosphere, e.g. of inert gas in a special atmosphere
- B65D81/2076—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents providing specific environment for contents, e.g. temperature above or below ambient under vacuum or superatmospheric pressure, or in a special atmosphere, e.g. of inert gas in a special atmosphere in an at least partially rigid container
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
- B65D81/24—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants
- B65D81/26—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants with provision for draining away, or absorbing, or removing by ventilation, fluids, e.g. exuded by contents; Applications of corrosion inhibitors or desiccators
- B65D81/266—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants with provision for draining away, or absorbing, or removing by ventilation, fluids, e.g. exuded by contents; Applications of corrosion inhibitors or desiccators for absorbing gases, e.g. oxygen absorbers or desiccants
Definitions
- the present invention is directed to systems and methods for avoiding the creation of a vacuum in packaged containers.
- the avoidance in creating the vacuum helps prevent buckling of the package and improves shelf life of the packaged material.
- Another method to address degradation issues related to oxygen degradation is to add an oxygen scavenger inside the packaging prior to sealing.
- the oxygen scavenger e.g., iron oxide based
- Atmospheric air which is typically included in the headspace of packaging, is approximately 21% oxygen.
- the removal of oxygen from a sealed container using an oxygen scavenger can create a partial vacuum inside the container, which can lead to puckering of the package walls, package seal failure, and an increased permeation of gases through the package walls.
- package failure can lead to decreased shelf life and a product that is unsuitable for standard distribution channels.
- One method to reduce buckling and package failure due to vacuum creation would be to increase the thickness of the container walls. However, this would result in a heavier product for distribution that could add significantly to the cost of goods. In addition, increasing the thickness of the container walls might not prevent package seal failure.
- the product is a pharmaceutical drug product.
- the product is an industrial chemical.
- the product is a foodstuff.
- the present invention provides a packaging system comprising: (i) a sealable container having an inner cavity; (ii) a product (e.g., a consumer or industrial product); (iii) a gas removing material; and (iv) a gas releasing material.
- a packaging system comprising: (i) a sealable container having an inner cavity; (ii) a product (e.g., a consumer or industrial product); (iii) a gas removing material; and (iv) a gas releasing material.
- the present invention provides a packaging system comprising: (i) a sealable container having an inner cavity; (iii) a gas removing material; and (iv) a gas releasing material.
- the packaging system is adapted to receive a product (ii) as described above, and is then sealed for distribution and marketing.
- the present invention provides a packaging system comprising: (i) a sealable container having an inner cavity; (ii) a product (e.g., a consumer or industrial product); and (iii) a gas releasing material.
- a product e.g., a consumer or industrial product
- a gas releasing material e.g., a gas releasing material
- the present invention provides a packaging system comprising: (i) a sealable container having an inner cavity; and (iii) a gas releasing material.
- the packaging system is adapted to receive a product (ii) as described above, and is then sealed for distribution and marketing.
- the product can be a pharmaceutical drug, a foodstuff or a commercial or industrial chemical.
- the product is subject to oxidative degradation.
- the gas removing material is an oxygen scavenger, an oxygen adsorbent or a combination thereof.
- gas liberated from the gas releasing material serves to replace the gas removed by the gas removing material, e.g. the oxygen removed by an oxygen scavenger.
- the packaging system avoids or reduces the creation of an inner vacuum, thereby preventing buckling of the container or package seal failure.
- the present invention provides a packaging system comprising: (i) a sealable container having an inner cavity; (ii) a product (e.g., a consumer or industrial product); (iii) an oxygen scavenger or adsorbent; and (iv) a gas releasing material, wherein gas liberated from the gas releasing material serves to replace the oxygen removed by the oxygen scavenger.
- a packaging system By replacing the scavenged (or adsorbed) oxygen with gas liberated from the gas releasing material, the packaging system avoids or reduces the creation of an inner vacuum, thereby preventing or minimizing buckling of the container or package seal failure.
- the gas liberated from the gas releasing material is an inert gas (such as nitrogen).
- an inert gas such as nitrogen
- the sealable container can be any container that can be used for and/or is approved for storing, shipping, distributing and/or marketing a particular product, whether that product is an active pharmaceutical ingredients (API), a pharmaceutical dosage form in finished form, or any industrial chemical or other material that needs to be stored, shipped or distributed.
- the sealable container can be any such container that can be sealed against the passage of gases, and for which oxygen scavenging would help improve the stability of the material contained therein.
- sealable containers for pharmaceutical use include drug bottles, vials or other sealable drug-containing packages provided directly to consumers; bulk containers (e.g., bottles) of drugs distributed by pharmaceutical manufacturers and pharmaceutical distributors to pharmacy chains, outlets and hospitals; and industrial size bins, drums and bags used by pharmaceutical companies to store large quantities of drug intermediates, API or finished dosage forms.
- Non-limiting examples of sealable containers for non-pharmaceutical chemicals include bottles, vials or other sealable chemical-containing packages provided directly to academic or research laboratories; bulk containers (e.g., bottles) of chemicals distributed by chemical manufacturers and chemical distributors to chemical clearinghouses; and industrial size bins, drums and bags used by chemical companies for storing, shipping, distributing or marketing industrial chemicals.
- the sealable container is adapted to contain the product, the gas removing material and the gas releasing material, and then to be sealed for storage, distribution and/or marketing.
- the gas removing material and the gas releasing material are preferably maintained away from the product within the sealable container so as to prevent them from intermixing with the product, but so as to allow them to achieve their intended purposes of protecting the product by oxygen scavenging and liberation of the replacement gas.
- the gas-removing material and the gas releasing material are preferably maintained in one or more separate sub-containers within the sealable container, such as in one or more pouches or sachets, perforated vials, or other appropriate sub-containers that are sufficiently permeable to the passage of gases so as to allow them to achieve their intended purposes.
- the gas removing material and the gas releasing material are maintained away from each other in separate sub-containers within the sealable container.
- the gas-removing material and the gas releasing material are maintained together in the same sub-container within the sealable container.
- the gas releasing material may be selected from a saccharide, a sugar alcohol, a starch, a dextrin, a gelatin, a gum, a protein and a combination thereof.
- the present invention further provides a method of packaging a product subject to oxidative degradation, comprising combining the product with an oxygen scavenger and gas releasing material in a sealable container, and sealing the container.
- the different recited components can be added in any order prior to sealing of the container.
- the present invention further provides specific gas releasing materials that can be utilized in the packaging systems and methods disclosed herein.
- air means atmospheric air that contains by volume approximately 78% nitrogen, 21% oxygen, 0.9% argon, 0.04% carbon dioxide, small amounts of other gases and a variable amount of water vapor.
- consumer product means any article, or component part thereof, produced or distributed for sale to a consumer for use in or around a residence, a school, in recreation, or otherwise.
- consumer products are foodstuffs, pharmaceuticals, household chemicals and lawn and gardening products.
- the term "industrial product” means any article, or component part thereof, produced or distributed for sale to a business for use in or around a workplace, industrial setting, or agricultural setting.
- industrial products are bulk foodstuffs or components, bulk pharmaceuticals or components, industrial chemicals and agricultural products.
- fluid communication means the free transfer of a gas, fluid, or other substance from one area to another.
- adsorbent means a material, typically porous and with a high surface area, that can adsorb substances onto its surface by intermolecular forces.
- gas releasing material means a substance that can keep a gas under increased pressure.
- scavenger means any material that is capable of reacting with a target material in order to reduce or minimize the presence of the target material in an environment of use.
- Figure 1 is a depiction of an apparatus to measure the amount of gas in gas releasing materials before or after exposure to controlled conditions.
- the present invention addresses the issue of package disruption (e.g., puckering, buckling, seal breakage) due to the creation of an inner vacuum.
- the inner vacuum can be caused by a variety of factors, including but not limited to the use of adsorbents or scavengers to maintain or improve stability of the packaged product by the removal of oxygen from the sealed container.
- Other causes of inner vacuum and package disruption include cooling of packaged goods after being subject to heat, e.g., in sterilization processes, and removal of water or reactive gases by suitable scavengers from the sealed container..
- the present invention utilizes a gas releasing material in order to avoid or reduce the creation of a vacuum in the packaging system, and to thereby minimize or prevent the disruption of the package seal.
- the gas releasing material is designed to liberate gas upon activation (e.g., by an external stimulus) or spontaneously over time.
- the packaging system of the present invention comprises: (i) a sealable container having an inner cavity; (ii) a product subject to degradation by a gas, e.g., to oxidative degradation; (iii) a gas removing material; and (iv) a gas releasing material capable of liberating an effective amount of gas to replace at least a portion of the gas removed by the gas removing material (e.g., scavenger or adsorbent) in order to avoid or reduce the formation of a vacuum in the sealable container.
- a gas removing material e.g., scavenger or adsorbent
- the gas releasing material is in the form of a solid matrix containing a compressed gas.
- the gas releasing material can be prepared, e.g., in accordance with the description of US Patent No. 3,012,893, US Patent No. 4,001,457 and US Patent No. 4,289,794, which are generally directed to preparing a gas releasing confection or candy.
- Such gas releasing candy is commercially available under the tradename PopRocks ® .
- the gas releasing material is prepared in certain embodiments by contacting a gas (e.g., any combination of nitrogen, inert gases like helium, carbon dioxide, air, etc.) with the matrix material (e.g., a saccharide) in a molten or semi-molten state.
- a gas e.g., any combination of nitrogen, inert gases like helium, carbon dioxide, air, etc.
- the matrix material e.g., a saccharide
- the gas is pressurized (e.g., at about 50 to 1000 psig) and is contacted with the molten matrix material for a sufficient time to permit adsorption of the gas therein.
- the gas can be in an amount of about 0.5 to about 25 mL per gram of matrix material.
- the matrix material is maintained in a molten or semi-molten state and when the desired concentration of gas is achieved, the gas-infused material is cooled and solidified to obtain the gas releasing material.
- the gas releasing material can then be processed into a desired shape and size, e.g., in the form of multiparticulates with a mean size from about 500 ⁇ to about 3 mm, from about 0.1 mm to about 2 mm or from about 0.5 mm to about 1 mm.
- the processing of the gas releasing material into a desired shape and size can be performed, e.g., by milling and an optional sieving step.
- the milling can be performed, e.g., with a batch ball mill, continuous ball mill, vibrating ball mill, cage mill, colloid mill, fluid energy mill, hammer mill, pebble batch mill, pellet mill, or air classifying mill.
- Commercially available equipment that can be utilized in the milling process is a Frewitt Mill, Comil, or Fitzmill.
- the milled material can be sieved to obtain a desired size range of particles, e.g., with a Sweco vibratory separator, Russell sieve or a simple hand sieve.
- the gas releasing material can be prepared utilizing methods comprising hot melt extrusion or injection molding.
- the gas can be added to the melted material in the extruder and the extruded material can be injected into a mold and quickly cooled to shape. After release from the mold, the gas releasing material may retain the shape of the mold or may spontaneously crack into smaller particles. Further milling and sieving may optionally be performed on the molded material.
- extrusion equipment that can be utilized in such processes include a single or twin screw extruder such as a Brabender or a Leistritz.
- An example of an injection molding apparatus is a B-Side Crane NW, 3-Ton, 12' High, Model Yale KEL3-15RT1053. The addition of a gear pump between the extruder and the mold may facilitate the process.
- the gas releasing material can be extruded into a strand and be cut or chopped into a desired size.
- the strand can be extruded into a cooling media (such as chilled air or oil) to facilitate the size reduction.
- the process is performed above atmospheric pressure to reduce "die swell", which is the expansion of the extrudate to a size larger than the extruder orifice.
- the gas which is contained in the gas releasing material can be any gas, but is typically a gas which contains no amount or reduced amounts (in comparison to air) of gaseous compounds (e.g., oxygen) which could be detrimental for the packaged product. It is in one embodiment not air.
- the gas is selected from the group consisting of nitrogen, carbon dioxide and inert gases, and more preferably is nitrogen or carbon dioxide.
- the matrix material that is the basis of the gas releasing material can include but is not limited to a material selected from the group consisting of a carbohydrate (e.g., a saccharide, a starch or dextrin), a gelatin, a gum, a protein and a combination thereof.
- a carbohydrate e.g., a saccharide, a starch or dextrin
- a gelatin e.g., a starch or dextrin
- carbohydrate refers to a monosaccharide
- disaccharide oligosaccharide; digestible, partially digestible and non-digestible polysaccharide; and sugar alcohol.
- Monosaccharides that can be utilized in the present invention include but are not limited to glucose, fructose, mannose, idose, galactose, allose, gulose, altrose, talose, fucose, erythrose, threose, lyxose, erythrulose, ribulose, xylulose, ribose, arabinose, xylose, psicose, sorbose, tagatose, glyceraldehyde, dihydroxyacetone, rhamnose and mixtures thereof.
- Disaccharides that can be utilized in the present invention include but are not limited to sucrose, maltose, lactose, trehalose, cellobiose, invert sugar and mixtures thereof.
- Oligosaccharides that can be utilized in the present invention include but are not limited to maltotriose, raffinose, cellotriose, manninotriose, fructooligosaccharide, stachyose, corn syrup solids and mixtures thereof.
- Polysaccharides that can be utilized in the present invention include, but are not limited to digestible polysaccharides and non-digestible polysaccharides.
- digestible polysaccharides include starches that are isolated or derived from cereal grains, legumes, tubers and roots; maltodextrins; glycogen; native, unmodified starches; pre-gelatinized starches; chemically modified starches; high amylose starches; waxy starches; and mixtures thereof.
- Non-digestible polysaccharides may be water-soluble or water-insoluble.
- Non- limiting examples of water-soluble or predominately water-soluble, non-digestible polysaccharides include: oat bran; barley bran; psyllium; pentosans; plant extracts such as pectins, inulin, and beta-glucan soluble fiber; seed galactomannans such as guar gum, and locust bean gum; plant exudates such as gum arabic, gum tragacanth, and gum karaya; seaweed extracts such as agar, carrageenans, alginates, and furcellaran; cellulose derivatives such as carboxymethylcellulose, hydroxypropylmethylcellulose and methylcellulose; microbial gums such as xanthan gum and gellan gum; hemicellulose; polydextrose; and mixtures thereof.
- Non-limiting examples of water-insoluble, and predominately water-insoluble, non-digestible polysaccharides include cellulose;
- microcrystalline cellulose cellulose
- brans cellulose
- resistant starch and mixtures thereof.
- the polysaccharides of the present invention can also include chitosan and derivatives thereof such as trimethylchitosan.
- Sugar alcohols that can be utilized in the present invention include, but are not limited to glycerol, sorbitol, xylitol, mannitol, maltitol, propylene glycol, erythritol and mixtures thereof.
- the gas releasing material of the present invention can be prepared in order to liberate gas upon activation or spontaneously over time.
- the gas releasing material will typically liberate gas spontaneously over a period of time without the need for any external stimulus or activation.
- the rate at which the material releases gas can be determined during the manufacturing process by varying factors such as the volume of gas per weight of matrix material and the pressure of the gas contained in the material. Accordingly, in certain embodiments, depending on the rate of spontaneous release of gas from the gas releasing material, a sufficient amount of gas releasing material can be incorporated into a packaging system to counteract the formation and negative effects of an inner vacuum.
- the inner vacuum resulting from the removal of gas by scavengers may reach a maximum within 2-3 days after sealing or more.
- the rate of spontaneous release of gas by the gas releasing material may not be sufficient during that initial time period to prevent package failure. Therefore, in certain embodiments of the present invention, the gas releasing material is designed to release the desired amount of gas upon activation, e.g., by an external or internal stimulus.
- the activation method can include a pressure change, temperature change, moisture change, or application of a magnetic field, radiation or a combination thereof.
- the radiation can comprise electromagnetic radiation including ultraviolet radiation, microwave radiation, IR radiation, an induction field or a combination thereof.
- the gas releasing material preferably liberates gas at a temperature below the melting point of the gas releasing material as to maintain the integrity of the system. However, if the gas releasing material has sufficient viscosity above the melting point, the liberation temperature may be higher
- a susceptor i.e., a system that converts electromagnetic radiation to heat can be utilized in embodiments that rely on activation of the gas releasing material.
- the susceptor material can be packaged with the gas releasing material such that the gas is liberated by the heat or IR radiation resulting from exposure of the system to
- the use of susceptors could be used in order to minimize exposure (amount and duration) of the total system to external heat.
- the temperature of the packaged product would not be significantly affected and would not have a significant adverse effect on stability and shelf life.
- one material such as elemental iron or aluminum can have both scavenger and susceptor properties in order to reduce the number of components in the system.
- the stimulus that activates the liberation of gas from the gas releasing material is internal and does not require the use of an external stimulant.
- the heat generated by the reaction of oxygen with an oxygen scavenger could be sufficient to activate the liberation of gas from the gas releasing material.
- an oxygen scavenger e.g., iron
- the scavenger and the gas releasing material must be in sufficient proximity or contact to effect the activation.
- the gas releasing material can be packaged at a low temperature such that gas is liberated after a specific period at room temperature or at a different humidity within the interior of the container.
- the gas releasing material has the ability to liberate gas upon the introduction of moisture to the material.
- the packaging system of the invention can utilize a scavenger that has desiccant properties (i.e., the ability to absorb moisture) or include a separate desiccant component in the packaging system. The absorbed moisture by the scavenger (or desiccant) could then be utilized as an activator for the gas releasing material to release gas and reduce or minimize the inner vacuum.
- the scavenger and the gas releasing material must be in sufficient proximity or contact to effect the activation.
- Iron is an example of a scavenger that can be designed to release moisture upon introduction to the packaging system.
- the scavenger can be selected from those that can be activated either during or after the packaging process. This is particularly an advantage for scavengers that have a limited duration of action so as to ensure they are within the packaging system for the majority or entire duration of their activity.
- the same stimulus can activate both the scavenger and the gas releasing material.
- the external activation can utilize existing equipment (such as heat generated by an induction sealer) in order to avoid the need for a separate activation step and the necessity of additional equipment.
- the scavenger, gas releasing material or both are included in the liner of a container cap, where it can readily be exposed to heat generated by the induction sealer. The inclusion in the cap, or elsewhere in the container, would reduce the need to introduce a separate processing step for the insertion of the scavenger and/or gas releasing material.
- the gas releasing material can serve a dual purpose to avoid or reduce the creation of an inner vacuum and to act as a desiccant to further improve the stability of the packaged goods.
- the ability of the gas releasing material to absorb moisture acts as a self-contained stimulus to liberate gas, without the need for a separate stimulus or desiccant.
- the sealed package can be subject to the external stimulus (e.g., heat, radiation) before, during or after the development of any internal vacuum.
- the external stimulus to liberate gas from the gas releasing material will be within a sufficient time to prevent package failure.
- the external stimulus will be before or during the creation of any inner vacuum, which may result in a package having increased internal pressure until the scavenger has reacted with and removed the intended gas.
- Such embodiments are suitable for the purposes of the present invention provided that the integrity of the package and/or the seal is maintained during the time of increased pressure.
- the gas removing material i.e., the scavenger or adsorbent
- a sub-container comprising a housing having at least one internal compartment in fluid communication with the exterior of the housing.
- the gas removing material and the gas releasing material can both be contained in the device, either separately or interdispersed.
- the materials can be contained in the device in different compartments or in the same compartment.
- the housing material can comprise a material selected from the group consisting of plastic, paper, fabric, metal and a combination thereof. The inclusion of both the gas removing material and the gas releasing material in the same device would streamline and facilitate packaging processes.
- the gas releasing material in the packaging system of the present invention preferably liberates an effective amount of gas to replace at least a portion of the gas (e.g., oxygen) removed by the gas removing material.
- the volume of gas that is liberated is the same or substantially the same as the volume of gas removed by the scavenger.
- the volume of liberated gas is higher or lower than the volume of removed gas.
- the volume of liberated gas minimizes or eliminates vacuum buckling or seal breaking of the container due to the activity of the scavenger.
- the volume of liberated gas should also not exceed the amount of removed gas to an extent that the integrity of the package and/or seal is compromised.
- a 75 cc bottle filled with pharmaceutical tablets could contain about 50 cm 3 of head space.
- the oxygen in 50 cm 3 would be approximately 10 cm 3 .
- the packaging system could include approximately 2 grams of gas releasing material containing about 5 cm 3 of gas/gram.
- the oxygen scavengers utilized in the present invention can include metal-based scavengers such as iron.
- metal-based scavengers such as iron.
- a finely powdered activated metal enters the oxide state when exposed to the proper moisture, effectively binding oxygen in the process.
- the powdered scavengers can be contained by any suitable means, e.g., in a permeable housing or sachet.
- the scavenger can also be included in the packaging systems as an inner coating or directly within the container material, e.g., by way of an extrusion additive.
- Oxygen scavengers that can be utilized in the present invention include those based on metal, catechol, oxidative enzymes, unsaturated hydrocarbons or polyamides.
- the oxygen scavengers utilized in the present invention can also be, e.g., low molecular weight organic compounds such as ascorbic acid or sodium ascorbate, which bind oxygen by oxidizing carbon-carbon double bonds, and/or a polymeric based oxygen scavenging resin with a catalyst, which binds oxygen through oxidation of the polymers.
- oxygen scavengers that can be utilized in the present invention include Ageless® products available from Mitsubishi Gas Chemical Co.
- Adsorbents e.g., oxygen adsorbents
- Adsorbents utilized in the present invention may be based on, e.g., zeolite, charcoal, silica or combinations thereof.
- Commercially available adsorbents are supplied by Multisorb Technologies Inc. and Sud-Chemie, among other companies.
- a gas removing material and/or a susceptor can be directly incorporated into the gas releasing material.
- these materials can be added to the gas releasing material in its molten or semi-molten state, either before, during or after contact with pressurized gas.
- these materials can be infused into the gas releasing material during the cooling process or after solidification of the molten matrix material.
- the packaging material of the present invention can be a plastic that is substantially impermeable to gas. However, these materials still are susceptible to leaching of outside gas into the container. There is typically a greater ability to leach into the inner container when the vacuum is internally created, which results in the buckling and puckering of the container due to the pressure difference. Although materials with decreased permeability (e.g., glass, metal and thicker plastics) may be resistant to buckling and puckering, the present invention can still be useful when utilizing these container materials by minimizing or eliminating seal failure, which can be caused by the same factors which result in buckling and puckering of the container itself.
- materials with decreased permeability e.g., glass, metal and thicker plastics
- the avoidance or reduction of inner vacuum by the present invention can decrease the influx of outside air into the container. Therefore, the present invention may have the benefit of lowering the amount of scavenger material needed in the packaging system or decreasing the time necessary for the scavenger to become effective. This may also enable the use of thinner walled and/or more permeable packaging to decrease the net weight and costs of manufacture and distribution.
- Products that can be packaged in the systems of the present invention include any product which may degrade in the presence of oxygen or other reactive gases, e.g., certain pharmaceutical drugs, foodstuffs, and industrial chemicals.
- Non-limiting examples of food products that can be packaged according to the present invention include but are not limited to coffee, tea, milk, yogurt, ice cream, cheeses, stews, soups, meat products (e.g., hot dogs, cold cuts, chicken and beef jerky), single-serving pre-cooked meals and side dishes, homemade pasta, spaghetti sauce, condiments (e.g., barbecue sauce, ketchup, mustard and mayonnaise), beverages (e.g., fruit juice, wine and beer); dried fruits, dried vegetables, breakfast cereals, baked goods (e.g., bread, crackers, pastries, cookies, and muffins), snack foods (e.g., candy, potato chips, pretzels and cheese-filled snacks), peanut butter, jelly, peanut butter and jelly combinations, jams, dried or fresh seasonings, pet and animal foods and the like.
- meat products e.g., hot dogs, cold cuts, chicken and beef jerky
- condiments e.g., barbecue sauce, ketchup, mustard and mayonnaise
- beverages e.g.
- Non-limiting examples of pharmaceutical active agents generally susceptible to oxidation include those containing amine, hydroxyl, and thiol groups.
- a particular class of active agents that can be utilized in the present invention are opioid agonists which include, but are not limited to, alfentanil, allylprodine, alphaprodine, anileridine, benzylmorphine, bezitramide, buprenorphine, butorphanol, clonitazene, codeine, desomorphine, dextromoramide, dezocine, diampromide, diamorphone, dihydrocodeine, dihydromorphine, dimenoxadol, dimepheptanol, dimethylthiambutene, dioxaphetyl butyrate, dipipanone, eptazocine, ethoheptazine, ethylmethylthiambutene, ethylmorphine, etonitazene fentanyl,
- phenadoxone phenomorphan
- phenazocine phenoperidine
- piminodine piritramide
- proheptazine promedol
- properidine propiram
- propoxyphene sufentanil
- tilidine tramadol
- pharmaceutically acceptable salts thereof and mixtures thereof.
- the opioid agonist is selected from codeine,
- hydromorphone hydrocodone, oxycodone, dihydrocodeine, dihydromorphine, morphine, tramadol, oxymorphone, pharmaceutically acceptable salts thereof, and mixtures thereof.
- non opioid analgesics include, but are not limited to, non steroidal anti-inflammatory agents, such as aspirin, ibuprofen, diclofenac, naproxen, benoxaprofen, flurbiprofen, fenoprofen, flubufen, ketoprofen, indoprofen, piroprofen, carprofen, oxaprozin, pramoprofen, muroprofen, trioxaprofen, suprofen, aminoprofen, tiaprofenic acid, fluprofen, bucloxic acid, indomethacin, sulindac, tolmetin, zomepirac, tiopinac, zidometacin, acemetacin, fentiazac, clidanac, oxpinac, mefenamic
- non opioid analgesics include, but are not limited to, non steroidal anti-inflammatory agents, such as aspir
- non opioid analgesics include the following, non limiting, chemical classes of analgesic, antipyretic, nonsteroidal antiinflammatory drugs: salicylic acid derivatives, including aspirin, sodium salicylate, choline magnesium trisalicylate, salsalate, diflunisal, salicylsalicylic acid, sulfasalazine, and olsalazin; para aminophennol derivatives including acetaminophen and phenacetin; indole and indene acetic acids, including indomethacin, sulindac, and etodolac; heteroaryl acetic acids, including tolmetin, diclofenac, and ketorolac; anthranilic acids (fenamates), including mefenamic acid, and meclofenamic acid; enolic acids, including oxicams (piroxicam, tenoxicam), and pyrazolidinediones (phenylbutazone,
- the gas releasing material of the present invention can be utilized for different purposes other than to avoid or reduce creation of a vacuum in a packaging system.
- the gas liberated from the gas releasing material can be utilized as an indicator that the particular package has been exposed to unwanted conditions such as heat or moisture during its storage or distribution.
- the liberated gas upon exposure to these conditions could activate an indicator, such as the protrusion of a seal.
- a sufficient amount of the resultant gas releasing material is incorporated into a sealed container with a pharmaceutical product susceptible to oxidative degradation and an iron based oxygen scavenger.
- PopRocks® Commercially available PopRocks® are obtained and a sufficient amount is incorporated into a sealed container with a pharmaceutical product susceptible to oxidative degradation and an iron based oxygen scavenger.
- the characteristics of the gas releasing material can be measured by subjecting the gas releasing material to a variety of conditions/times and testing for the amount of remaining gas in the material.
- an amount of gas releasing material can be placed in an open dish in a vacuum oven as a function of:
- the remaining gas in the gas releasing material can be tested against an established baseline.
- One method to measure the amount of remaining gas is to place the gas releasing material in water to liberate all of the remaining gas and take a
- the baseline can be established using the same procedure.
- Figure 1 shows a container (1) containing a gas releasing material (2) placed in a cup with magnets (3).
- the container is attached with tubes (4) to a syringe (5) and a pipette (6).
- the pipette is modified by having the fat end cut and immersed in water.
- the container is sealed and water is drawn up to a measurement line (7) on the pipette with the syringe.
- the syringe is detached and the plunger is depressed and decompressed without changing the water level.
- the cup is rotated from the outside with the magnets and the gas releasing material falls into the water and gas is evolved.
- the evolved gas will lower the water volume from the measurement line on the pipette.
- the plunger on the syringe is withdrawn until the water returns to the water level line.
- the volume on the syringe will represents the volume of gas evolved from the gas releasing material.
- One method to maintain a desired humidity level is to utilize particular saturated salts which maintain specific humidities as a function of temperature.
- saturated salts which can be utilized include potassium hydroxide, lithium chloride, potassium acetate, magnesium chloride, potassium carbonate, magnesium nitrate, sodium dichromate, ammonium nitrate, sodium nitrite, sodium chloride, ammonium sulphate, potassium chloride, potassium nitrate, and potassium sulphate.
- the temperature and humidity can be measured by a temperature/humidity logger.
- Another method to measure the amount of remaining gas and/or to establish a baseline is to use a grab sampling tube that is filled with small granules of a special chemical that has a very high ability to absorb the gas that is being measured.
- This chemical is called a sorbent.
- hydrazine hydrate or sodium hydroxide coated silica e.g., ASCARITE II®
- ASCARITE II® sodium hydroxide coated silica
- HDPE Bottles were chosen to be 36.3 mm thick (front to back) and 46.6 mm (side to side) and were packaged and labeled in the following configuration:
- Bottle 1 4 g Pop Rock; 0 2 absorbing canister; foil strip.
- Bottle 3 0 2 absorbing canister
- Bottles 1 and 3 were concave front to back and remained convex side to side Bottle 2 remained convex at all sides.
- the dimensional changes in the bottles from the initial measurements to the measurements in Table 1 are set forth in Table 2 below:
- Bottle 1 The difference between Bottle 1 and Bottle 3 indicates that some of the gas was released from the Pop Rocks spontaneously without the necessity to provide an activation step.
- Bottle 1 was placed in an inverted induction sealer.
- the sealer was set to 2.00 seconds and activated. This was done 4 times for each bottom corner of the bottle. Popping was heard on the first 3 corners, but not the fourth. The popping sound indicates that the induction sealer heated the foil which activated the gas releasing material to release an amount of gas.
- the system was allowed to cool for about 4 hours and measurements were repeated as set forth in Table 3 below: Table 3
Landscapes
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Life Sciences & Earth Sciences (AREA)
- Food Science & Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Packages (AREA)
- Vacuum Packaging (AREA)
Abstract
Disclosed in certain embodiments is a packaging system comprising a container (1) having an inner cavity; a product subject to degradation; a gas removing material (2); and a gas releasing material, wherein the gas releasing material is capable of liberating an effective amount of gas to replace at least a portion of the gas removed by the gas removing material in order to minimize buckling of the container.
Description
VACUUM AVOIDING PACKAGING SYSTEMS AND METHODS THEREOF
FIELD OF THE INVENTION
[0001] The present invention is directed to systems and methods for avoiding the creation of a vacuum in packaged containers. The avoidance in creating the vacuum helps prevent buckling of the package and improves shelf life of the packaged material.
BACKGROUND OF THE INVENTION
[0002] The packaging and distribution of consumer products present many challenges, especially when the product is subject to degradation and has a limited shelf-life. This is especially true when the product is a pharmaceutical drug subject to testing under storage conditions in order to obtain regulatory approval. Many degradation issues of such packaged products are associated with the presence of oxygen in the headspace of the container.
[0003] Oxygen exists in two allotropic forms: as an invisible gas composed of two oxygen atoms (02); and as a perceptibly blue form composed of three oxygen atoms (03 or ozone). Unlike nitrogen or carbon dioxide, oxygen is paramagnetic wherein two electrons in the molecule are not paired to each other. These "free unpaired" electrons can interact with and cause degradation of many packaged products to create "free radicals". The typical reaction is by hydrogen abstraction and formation of peroxides, which decompose to free radicals. The presence of peroxides causes further degradation of the packaged products.
[0004] In the case of pharmaceutical drugs, the degradation due to oxidation has the potential to reduce the amount of active agent so that the dosage form no longer contains the labeled amount of active agent. In certain cases, the inadequate stability of an active agent could result in an otherwise safe and efficacious pharmaceutical drug becoming non-approvable and therefore not available to provide benefit to the intended patient population.
[0005] The issue of air (and thus oxygen) in the headspace of packaging may be addressed by packaging the product with an inert gas (e.g., nitrogen) in place of air in the headspace. Procedures to carry this out may utilize liquid nitrogen, but this creates safety concerns, including the possibility of freeze burns when converting the liquid nitrogen to a gas, and the propensity of nitrogen to crowd out oxygen in confined spaces. Inert gas replacement procedures, equipment, and required maintenance can also significantly increase the cost of goods, which may have an adverse effect on distribution and marketing.
[0006] Another method to address degradation issues related to oxygen degradation is to add an oxygen scavenger inside the packaging prior to sealing. The oxygen scavenger (e.g., iron oxide based) reacts with the oxygen and thereby reduces its contact with the packaged material.
[0007] Atmospheric air, which is typically included in the headspace of packaging, is approximately 21% oxygen. The removal of oxygen from a sealed container using an oxygen scavenger can create a partial vacuum inside the container, which can lead to puckering of the package walls, package seal failure, and an increased permeation of gases through the package walls. Such package failure can lead to decreased shelf life and a product that is unsuitable for standard distribution channels.
[0008] One method to reduce buckling and package failure due to vacuum creation would be to increase the thickness of the container walls. However, this would result in a heavier product for distribution that could add significantly to the cost of goods. In addition, increasing the thickness of the container walls might not prevent package seal failure.
[0009] Accordingly, there exists a need in the art to address problems associated with the packaging of consumer products.
[0010J All references described herein are incorporated by reference in their entireties for all purposes.
SUMMARY OF THE INVENTION
[0011] It is an object of the present invention to provide a packaging system for a product, which packaging system avoids or reduces the creation of an inner vacuum.
[0012] It is a further object of certain embodiments of the present invention to provide a packaging system that maintains the shelf life and stability of a product that might otherwise be susceptible to oxidative degradation. In certain embodiments, the product is a pharmaceutical drug product. In other embodiments, the product is an industrial chemical. In alternative embodiments, the product is a foodstuff.
[0013] It is a further object of certain embodiments of the present invention to provide a packaging system that maintains its integrity within distribution channels and during periods of storage.
[0014] It is a further object of certain embodiments of the present invention to provide a method of packaging a product to avoid or reduce the creation of an inner vacuum that might otherwise result from incorporating an oxygen scavenger in the packaged product.
[0015] It is a further object of certain embodiments of the present invention to provide a method of packaging a product that maintains the shelf life and stability of the product.
[0016] It is a further object of certain embodiments of the present invention to provide a method of packaging a product that maintains its integrity within distribution channels and during periods of storage.
[0017] It is a further object of certain embodiments of the present invention to provide a gas releasing material that can be utilized in a packaging system to avoid or reduce the
creation of an inner vacuum that might otherwise result from incorporating an oxygen scavenger therein.
[0018] It is a further object of certain embodiments of the present invention to provide a gas releasing material for use in a packaging system in conjunction with an oxygen scavenger that will help maintain the shelf life and stability of the packaged product.
[00191 It is a further object of certain embodiments of the present invention to provide a gas releasing material for use in a packaging system that will help maintain the integrity of the packaging system within distribution channels.
[0020] In one embodiment, the present invention provides a packaging system comprising: (i) a sealable container having an inner cavity; (ii) a product (e.g., a consumer or industrial product); (iii) a gas removing material; and (iv) a gas releasing material.
[0021] In another embodiment, the present invention provides a packaging system comprising: (i) a sealable container having an inner cavity; (iii) a gas removing material; and (iv) a gas releasing material. The packaging system is adapted to receive a product (ii) as described above, and is then sealed for distribution and marketing.
[0022] In another embodiment, the present invention provides a packaging system comprising: (i) a sealable container having an inner cavity; (ii) a product (e.g., a consumer or industrial product); and (iii) a gas releasing material. The container is adapted to contain the product and the gas releasing material as described above, and is then sealed for distribution and marketing.
[0023] In another embodiment, the present invention provides a packaging system comprising: (i) a sealable container having an inner cavity; and (iii) a gas releasing material. The packaging system is adapted to receive a product (ii) as described above, and is then sealed for distribution and marketing.
[0024] In certain embodiments, the product can be a pharmaceutical drug, a foodstuff or a commercial or industrial chemical. In particular embodiments, the product is subject to oxidative degradation.
[0025] In certain embodiments, the gas removing material is an oxygen scavenger, an oxygen adsorbent or a combination thereof.
[0026] In certain embodiments, gas liberated from the gas releasing material serves to replace the gas removed by the gas removing material, e.g. the oxygen removed by an oxygen scavenger. By replacing the scavenged (or adsorbed) oxygen with gas liberated from the gas releasing material, the packaging system avoids or reduces the creation of an inner vacuum, thereby preventing buckling of the container or package seal failure.
[0027] In another embodiment, the present invention provides a packaging system comprising: (i) a sealable container having an inner cavity; (ii) a product (e.g., a consumer or industrial product); (iii) an oxygen scavenger or adsorbent; and (iv) a gas releasing material, wherein gas liberated from the gas releasing material serves to replace the oxygen removed by the oxygen scavenger. By replacing the scavenged (or adsorbed) oxygen with gas liberated from the gas releasing material, the packaging system avoids or reduces the creation of an inner vacuum, thereby preventing or minimizing buckling of the container or package seal failure.
[0028] In another embodiment, the gas liberated from the gas releasing material is an inert gas (such as nitrogen). By replacing the scavenged (or adsorbed) oxygen with an inert gas liberated from the gas releasing material, the likelihood of oxidative degradation of the product is substantially reduced.
[0029] The sealable container can be any container that can be used for and/or is approved for storing, shipping, distributing and/or marketing a particular product, whether that product is an active pharmaceutical ingredients (API), a pharmaceutical
dosage form in finished form, or any industrial chemical or other material that needs to be stored, shipped or distributed. The sealable container can be any such container that can be sealed against the passage of gases, and for which oxygen scavenging would help improve the stability of the material contained therein. Other than practical
considerations, there is no lower or higher limit to the size or capacity of the sealable container for which the present invention may be used. Non-limiting examples of sealable containers for pharmaceutical use include drug bottles, vials or other sealable drug-containing packages provided directly to consumers; bulk containers (e.g., bottles) of drugs distributed by pharmaceutical manufacturers and pharmaceutical distributors to pharmacy chains, outlets and hospitals; and industrial size bins, drums and bags used by pharmaceutical companies to store large quantities of drug intermediates, API or finished dosage forms.
[0030] Non-limiting examples of sealable containers for non-pharmaceutical chemicals include bottles, vials or other sealable chemical-containing packages provided directly to academic or research laboratories; bulk containers (e.g., bottles) of chemicals distributed by chemical manufacturers and chemical distributors to chemical clearinghouses; and industrial size bins, drums and bags used by chemical companies for storing, shipping, distributing or marketing industrial chemicals.
[003 lj The sealable container is adapted to contain the product, the gas removing material and the gas releasing material, and then to be sealed for storage, distribution and/or marketing. The gas removing material and the gas releasing material are preferably maintained away from the product within the sealable container so as to prevent them from intermixing with the product, but so as to allow them to achieve their intended purposes of protecting the product by oxygen scavenging and liberation of the replacement gas. Thus, the gas-removing material and the gas releasing material are preferably maintained in one or more separate sub-containers within the sealable container, such as in one or more pouches or sachets, perforated vials, or other appropriate sub-containers that are sufficiently permeable to the passage of gases so as to allow them to achieve their intended purposes. In one embodiment, the gas removing
material and the gas releasing material are maintained away from each other in separate sub-containers within the sealable container. In another embodiment, the gas-removing material and the gas releasing material are maintained together in the same sub-container within the sealable container.
[0032] The gas releasing material may be selected from a saccharide, a sugar alcohol, a starch, a dextrin, a gelatin, a gum, a protein and a combination thereof.
[0033] The present invention further provides a method of packaging a product subject to oxidative degradation, comprising combining the product with an oxygen scavenger and gas releasing material in a sealable container, and sealing the container. The different recited components can be added in any order prior to sealing of the container.
[0034] The present invention further provides specific gas releasing materials that can be utilized in the packaging systems and methods disclosed herein.
[0035] As used herein, the term "air" means atmospheric air that contains by volume approximately 78% nitrogen, 21% oxygen, 0.9% argon, 0.04% carbon dioxide, small amounts of other gases and a variable amount of water vapor.
[0036] The term "consumer product" means any article, or component part thereof, produced or distributed for sale to a consumer for use in or around a residence, a school, in recreation, or otherwise. Non-limiting examples of consumer products are foodstuffs, pharmaceuticals, household chemicals and lawn and gardening products.
[0037] The term "industrial product" means any article, or component part thereof, produced or distributed for sale to a business for use in or around a workplace, industrial setting, or agricultural setting. Non-limiting examples of industrial products are bulk foodstuffs or components, bulk pharmaceuticals or components, industrial chemicals and agricultural products.
[0038] The term "fluid communication" means the free transfer of a gas, fluid, or other substance from one area to another.
[0039] The term "adsorbent" means a material, typically porous and with a high surface area, that can adsorb substances onto its surface by intermolecular forces.
[0040] The term "gas releasing material" means a substance that can keep a gas under increased pressure.
[0041] The term "scavenger" means any material that is capable of reacting with a target material in order to reduce or minimize the presence of the target material in an environment of use.
BRIEF DESCRIPTION OF THE DRAWING
[0042] Figure 1 is a depiction of an apparatus to measure the amount of gas in gas releasing materials before or after exposure to controlled conditions.
DETAILED DESCRIPTION
[0043] The present invention addresses the issue of package disruption (e.g., puckering, buckling, seal breakage) due to the creation of an inner vacuum. The inner vacuum can be caused by a variety of factors, including but not limited to the use of adsorbents or scavengers to maintain or improve stability of the packaged product by the removal of oxygen from the sealed container. Other causes of inner vacuum and package disruption include cooling of packaged goods after being subject to heat, e.g., in sterilization processes, and removal of water or reactive gases by suitable scavengers from the sealed container..
[0044] The present invention utilizes a gas releasing material in order to avoid or reduce the creation of a vacuum in the packaging system, and to thereby minimize or
prevent the disruption of the package seal. The gas releasing material is designed to liberate gas upon activation (e.g., by an external stimulus) or spontaneously over time.
[0045] In certain embodiments, the packaging system of the present invention comprises: (i) a sealable container having an inner cavity; (ii) a product subject to degradation by a gas, e.g., to oxidative degradation; (iii) a gas removing material; and (iv) a gas releasing material capable of liberating an effective amount of gas to replace at least a portion of the gas removed by the gas removing material (e.g., scavenger or adsorbent) in order to avoid or reduce the formation of a vacuum in the sealable container.
[0046] In certain embodiments, the gas releasing material is in the form of a solid matrix containing a compressed gas. The gas releasing material can be prepared, e.g., in accordance with the description of US Patent No. 3,012,893, US Patent No. 4,001,457 and US Patent No. 4,289,794, which are generally directed to preparing a gas releasing confection or candy. Such gas releasing candy is commercially available under the tradename PopRocks®.
[0047] The gas releasing material is prepared in certain embodiments by contacting a gas (e.g., any combination of nitrogen, inert gases like helium, carbon dioxide, air, etc.) with the matrix material (e.g., a saccharide) in a molten or semi-molten state. In this process, the gas is pressurized (e.g., at about 50 to 1000 psig) and is contacted with the molten matrix material for a sufficient time to permit adsorption of the gas therein. The gas can be in an amount of about 0.5 to about 25 mL per gram of matrix material. During processing, the matrix material is maintained in a molten or semi-molten state and when the desired concentration of gas is achieved, the gas-infused material is cooled and solidified to obtain the gas releasing material. The gas releasing material can then be processed into a desired shape and size, e.g., in the form of multiparticulates with a mean size from about 500 μπι to about 3 mm, from about 0.1 mm to about 2 mm or from about 0.5 mm to about 1 mm.
[0048] The processing of the gas releasing material into a desired shape and size can be performed, e.g., by milling and an optional sieving step. The milling can be performed, e.g., with a batch ball mill, continuous ball mill, vibrating ball mill, cage mill, colloid mill, fluid energy mill, hammer mill, pebble batch mill, pellet mill, or air classifying mill. Commercially available equipment that can be utilized in the milling process is a Frewitt Mill, Comil, or Fitzmill. If necessary, the milled material can be sieved to obtain a desired size range of particles, e.g., with a Sweco vibratory separator, Russell sieve or a simple hand sieve.
[0049] In other embodiments, the gas releasing material can be prepared utilizing methods comprising hot melt extrusion or injection molding. In these processes, the gas can be added to the melted material in the extruder and the extruded material can be injected into a mold and quickly cooled to shape. After release from the mold, the gas releasing material may retain the shape of the mold or may spontaneously crack into smaller particles. Further milling and sieving may optionally be performed on the molded material. Examples of extrusion equipment that can be utilized in such processes include a single or twin screw extruder such as a Brabender or a Leistritz. An example of an injection molding apparatus is a B-Side Crane NW, 3-Ton, 12' High, Model Yale KEL3-15RT1053. The addition of a gear pump between the extruder and the mold may facilitate the process.
[0050] In other embodiments the gas releasing material can be extruded into a strand and be cut or chopped into a desired size. The strand can be extruded into a cooling media (such as chilled air or oil) to facilitate the size reduction. In certain embodiments, the process is performed above atmospheric pressure to reduce "die swell", which is the expansion of the extrudate to a size larger than the extruder orifice.
[0051] The gas which is contained in the gas releasing material can be any gas, but is typically a gas which contains no amount or reduced amounts (in comparison to air) of gaseous compounds (e.g., oxygen) which could be detrimental for the packaged product. It is in one embodiment not air. In certain embodiments, the gas is selected from the
group consisting of nitrogen, carbon dioxide and inert gases, and more preferably is nitrogen or carbon dioxide.
[0052] The matrix material that is the basis of the gas releasing material can include but is not limited to a material selected from the group consisting of a carbohydrate (e.g., a saccharide, a starch or dextrin), a gelatin, a gum, a protein and a combination thereof.
[0053] As used herein, the term "carbohydrate" refers to a monosaccharide;
disaccharide; oligosaccharide; digestible, partially digestible and non-digestible polysaccharide; and sugar alcohol.
[0054] Monosaccharides that can be utilized in the present invention include but are not limited to glucose, fructose, mannose, idose, galactose, allose, gulose, altrose, talose, fucose, erythrose, threose, lyxose, erythrulose, ribulose, xylulose, ribose, arabinose, xylose, psicose, sorbose, tagatose, glyceraldehyde, dihydroxyacetone, rhamnose and mixtures thereof.
[0055] Disaccharides that can be utilized in the present invention include but are not limited to sucrose, maltose, lactose, trehalose, cellobiose, invert sugar and mixtures thereof.
[0056] Oligosaccharides that can be utilized in the present invention include but are not limited to maltotriose, raffinose, cellotriose, manninotriose, fructooligosaccharide, stachyose, corn syrup solids and mixtures thereof.
[0057] Polysaccharides that can be utilized in the present invention include, but are not limited to digestible polysaccharides and non-digestible polysaccharides. Non-limiting examples of digestible polysaccharides include starches that are isolated or derived from cereal grains, legumes, tubers and roots; maltodextrins; glycogen; native, unmodified starches; pre-gelatinized starches; chemically modified starches; high amylose starches; waxy starches; and mixtures thereof.
[0058] Non-digestible polysaccharides may be water-soluble or water-insoluble. Non- limiting examples of water-soluble or predominately water-soluble, non-digestible polysaccharides include: oat bran; barley bran; psyllium; pentosans; plant extracts such as pectins, inulin, and beta-glucan soluble fiber; seed galactomannans such as guar gum, and locust bean gum; plant exudates such as gum arabic, gum tragacanth, and gum karaya; seaweed extracts such as agar, carrageenans, alginates, and furcellaran; cellulose derivatives such as carboxymethylcellulose, hydroxypropylmethylcellulose and methylcellulose; microbial gums such as xanthan gum and gellan gum; hemicellulose; polydextrose; and mixtures thereof. Non-limiting examples of water-insoluble, and predominately water-insoluble, non-digestible polysaccharides include cellulose;
microcrystalline cellulose; brans; resistant starch; and mixtures thereof.
[0059] The polysaccharides of the present invention can also include chitosan and derivatives thereof such as trimethylchitosan.
[0060] Sugar alcohols that can be utilized in the present invention include, but are not limited to glycerol, sorbitol, xylitol, mannitol, maltitol, propylene glycol, erythritol and mixtures thereof.
[0061] The gas releasing material of the present invention can be prepared in order to liberate gas upon activation or spontaneously over time.
[0062] The gas releasing material will typically liberate gas spontaneously over a period of time without the need for any external stimulus or activation. The rate at which the material releases gas can be determined during the manufacturing process by varying factors such as the volume of gas per weight of matrix material and the pressure of the gas contained in the material. Accordingly, in certain embodiments, depending on the rate of spontaneous release of gas from the gas releasing material, a sufficient amount of gas releasing material can be incorporated into a packaging system to counteract the formation and negative effects of an inner vacuum.
[0063] In packaging systems utilizing oxygen scavengers, the inner vacuum resulting from the removal of gas by scavengers may reach a maximum within 2-3 days after sealing or more. The rate of spontaneous release of gas by the gas releasing material may not be sufficient during that initial time period to prevent package failure. Therefore, in certain embodiments of the present invention, the gas releasing material is designed to release the desired amount of gas upon activation, e.g., by an external or internal stimulus.
[0064] The activation method can include a pressure change, temperature change, moisture change, or application of a magnetic field, radiation or a combination thereof. The radiation can comprise electromagnetic radiation including ultraviolet radiation, microwave radiation, IR radiation, an induction field or a combination thereof. When a heat source is utilized as the stimulus, the gas releasing material preferably liberates gas at a temperature below the melting point of the gas releasing material as to maintain the integrity of the system. However, if the gas releasing material has sufficient viscosity above the melting point, the liberation temperature may be higher
[0065] A susceptor, i.e., a system that converts electromagnetic radiation to heat can be utilized in embodiments that rely on activation of the gas releasing material. The susceptor material can be packaged with the gas releasing material such that the gas is liberated by the heat or IR radiation resulting from exposure of the system to
electromagnetic radiation (e.g., a change in magnetic field). The use of susceptors could be used in order to minimize exposure (amount and duration) of the total system to external heat. In this embodiment, the temperature of the packaged product would not be significantly affected and would not have a significant adverse effect on stability and shelf life. In certain embodiments, one material such as elemental iron or aluminum can have both scavenger and susceptor properties in order to reduce the number of components in the system.
[0066] In certain embodiments, the stimulus that activates the liberation of gas from the gas releasing material is internal and does not require the use of an external stimulant. For example, in certain embodiments, the heat generated by the reaction of oxygen with an oxygen scavenger (e.g., iron) could be sufficient to activate the liberation of gas from the gas releasing material. In such an embodiment, the scavenger and the gas releasing material must be in sufficient proximity or contact to effect the activation. In another embodiment, the gas releasing material can be packaged at a low temperature such that gas is liberated after a specific period at room temperature or at a different humidity within the interior of the container.
[0067] In certain embodiments, the gas releasing material has the ability to liberate gas upon the introduction of moisture to the material. In such embodiments, the packaging system of the invention can utilize a scavenger that has desiccant properties (i.e., the ability to absorb moisture) or include a separate desiccant component in the packaging system. The absorbed moisture by the scavenger (or desiccant) could then be utilized as an activator for the gas releasing material to release gas and reduce or minimize the inner vacuum. In such an embodiment, the scavenger and the gas releasing material must be in sufficient proximity or contact to effect the activation. Iron is an example of a scavenger that can be designed to release moisture upon introduction to the packaging system.
[0068] The scavenger can be selected from those that can be activated either during or after the packaging process. This is particularly an advantage for scavengers that have a limited duration of action so as to ensure they are within the packaging system for the majority or entire duration of their activity. In certain embodiments, the same stimulus can activate both the scavenger and the gas releasing material. In other embodiments, there can be a cascade wherein a stimulus activates the scavenger which results in heat generation to activate the gas releasing material.
[0069] In certain embodiments, the external activation can utilize existing equipment (such as heat generated by an induction sealer) in order to avoid the need for a separate activation step and the necessity of additional equipment. In one embodiment, the
scavenger, gas releasing material or both, are included in the liner of a container cap, where it can readily be exposed to heat generated by the induction sealer. The inclusion in the cap, or elsewhere in the container, would reduce the need to introduce a separate processing step for the insertion of the scavenger and/or gas releasing material.
[0070] Additionally, many carbohydrates that can be utilized as the matrix for the gas releasing material will act as humectants by absorbing and holding moisture. Therefore, the gas releasing material can serve a dual purpose to avoid or reduce the creation of an inner vacuum and to act as a desiccant to further improve the stability of the packaged goods. In such an embodiment, the ability of the gas releasing material to absorb moisture acts as a self-contained stimulus to liberate gas, without the need for a separate stimulus or desiccant.
[0071] In certain embodiments, after the product is packaged with an oxygen scavenger and a gas releasing material and sealed, the sealed package can be subject to the external stimulus (e.g., heat, radiation) before, during or after the development of any internal vacuum. Preferably, the external stimulus to liberate gas from the gas releasing material will be within a sufficient time to prevent package failure. In certain embodiments, the external stimulus will be before or during the creation of any inner vacuum, which may result in a package having increased internal pressure until the scavenger has reacted with and removed the intended gas. Such embodiments are suitable for the purposes of the present invention provided that the integrity of the package and/or the seal is maintained during the time of increased pressure.
[0072] In certain embodiments, the gas removing material (i.e., the scavenger or adsorbent) is contained in a sub-container comprising a housing having at least one internal compartment in fluid communication with the exterior of the housing. The gas removing material and the gas releasing material can both be contained in the device, either separately or interdispersed. The materials can be contained in the device in different compartments or in the same compartment. The housing material can comprise a material selected from the group consisting of plastic, paper, fabric, metal and a
combination thereof. The inclusion of both the gas removing material and the gas releasing material in the same device would streamline and facilitate packaging processes.
[0073] The gas releasing material in the packaging system of the present invention preferably liberates an effective amount of gas to replace at least a portion of the gas (e.g., oxygen) removed by the gas removing material. Preferably, the volume of gas that is liberated is the same or substantially the same as the volume of gas removed by the scavenger. In some embodiments, the volume of liberated gas is higher or lower than the volume of removed gas. Preferably, the volume of liberated gas minimizes or eliminates vacuum buckling or seal breaking of the container due to the activity of the scavenger. The volume of liberated gas should also not exceed the amount of removed gas to an extent that the integrity of the package and/or seal is compromised.
[0074] By way of example, a 75 cc bottle filled with pharmaceutical tablets could contain about 50 cm3 of head space. The oxygen in 50 cm3 would be approximately 10 cm3. In such an embodiment, the packaging system could include approximately 2 grams of gas releasing material containing about 5 cm3 of gas/gram.
[0075] The oxygen scavengers utilized in the present invention can include metal-based scavengers such as iron. In metal based systems, a finely powdered activated metal enters the oxide state when exposed to the proper moisture, effectively binding oxygen in the process.
[0076] The powdered scavengers can be contained by any suitable means, e.g., in a permeable housing or sachet. The scavenger can also be included in the packaging systems as an inner coating or directly within the container material, e.g., by way of an extrusion additive.
[0077] Oxygen scavengers that can be utilized in the present invention include those based on metal, catechol, oxidative enzymes, unsaturated hydrocarbons or polyamides.
The oxygen scavengers utilized in the present invention can also be, e.g., low molecular weight organic compounds such as ascorbic acid or sodium ascorbate, which bind oxygen by oxidizing carbon-carbon double bonds, and/or a polymeric based oxygen scavenging resin with a catalyst, which binds oxygen through oxidation of the polymers.
Commercially available oxygen scavengers that can be utilized in the present invention include Ageless® products available from Mitsubishi Gas Chemical Co.
[0078] Adsorbents (e.g., oxygen adsorbents) utilized in the present invention may be based on, e.g., zeolite, charcoal, silica or combinations thereof. Commercially available adsorbents are supplied by Multisorb Technologies Inc. and Sud-Chemie, among other companies.
[0079] In certain embodiments, a gas removing material and/or a susceptor can be directly incorporated into the gas releasing material. For example, these materials can be added to the gas releasing material in its molten or semi-molten state, either before, during or after contact with pressurized gas. In other embodiments, these materials can be infused into the gas releasing material during the cooling process or after solidification of the molten matrix material.
[0080] The packaging material of the present invention can be a plastic that is substantially impermeable to gas. However, these materials still are susceptible to leaching of outside gas into the container. There is typically a greater ability to leach into the inner container when the vacuum is internally created, which results in the buckling and puckering of the container due to the pressure difference. Although materials with decreased permeability (e.g., glass, metal and thicker plastics) may be resistant to buckling and puckering, the present invention can still be useful when utilizing these container materials by minimizing or eliminating seal failure, which can be caused by the same factors which result in buckling and puckering of the container itself.
[0081] The avoidance or reduction of inner vacuum by the present invention can decrease the influx of outside air into the container. Therefore, the present invention may
have the benefit of lowering the amount of scavenger material needed in the packaging system or decreasing the time necessary for the scavenger to become effective. This may also enable the use of thinner walled and/or more permeable packaging to decrease the net weight and costs of manufacture and distribution.
[0082] Products that can be packaged in the systems of the present invention include any product which may degrade in the presence of oxygen or other reactive gases, e.g., certain pharmaceutical drugs, foodstuffs, and industrial chemicals.
[0083] Non-limiting examples of food products that can be packaged according to the present invention include but are not limited to coffee, tea, milk, yogurt, ice cream, cheeses, stews, soups, meat products (e.g., hot dogs, cold cuts, chicken and beef jerky), single-serving pre-cooked meals and side dishes, homemade pasta, spaghetti sauce, condiments (e.g., barbecue sauce, ketchup, mustard and mayonnaise), beverages (e.g., fruit juice, wine and beer); dried fruits, dried vegetables, breakfast cereals, baked goods (e.g., bread, crackers, pastries, cookies, and muffins), snack foods (e.g., candy, potato chips, pretzels and cheese-filled snacks), peanut butter, jelly, peanut butter and jelly combinations, jams, dried or fresh seasonings, pet and animal foods and the like.
[0084] Non-limiting examples of pharmaceutical active agents generally susceptible to oxidation include those containing amine, hydroxyl, and thiol groups. A particular class of active agents that can be utilized in the present invention are opioid agonists which include, but are not limited to, alfentanil, allylprodine, alphaprodine, anileridine, benzylmorphine, bezitramide, buprenorphine, butorphanol, clonitazene, codeine, desomorphine, dextromoramide, dezocine, diampromide, diamorphone, dihydrocodeine, dihydromorphine, dimenoxadol, dimepheptanol, dimethylthiambutene, dioxaphetyl butyrate, dipipanone, eptazocine, ethoheptazine, ethylmethylthiambutene, ethylmorphine, etonitazene fentanyl, heroin, hydrocodone, hydromorphone, hydroxypethidine, isomethadone, ketobemidone, levorphanol, levophenacylmorphan, lofentanil, meperidine, meptazinol, metazocine, methadone, metopon, morphine, myrophine, nalbuphine, narceine, nicomorphine, norlevorphanol, normethadone, nalorphine, normorphine,
norpipanone, opium, oxycodone, oxymorphone, papavereturn, pentazocine,
phenadoxone, phenomorphan, phenazocine, phenoperidine, piminodine, piritramide, proheptazine, promedol, properidine, propiram, propoxyphene, sufentanil, tilidine, tramadol, pharmaceutically acceptable salts thereof, and mixtures thereof.
[0085] In certain embodiments, the opioid agonist is selected from codeine,
hydromorphone, hydrocodone, oxycodone, dihydrocodeine, dihydromorphine, morphine, tramadol, oxymorphone, pharmaceutically acceptable salts thereof, and mixtures thereof.
[0086] Other pharmaceutical active agents that can be included in the packaging systems of the present invention include non opioid analgesics. Examples of non opioid analgesics include, but are not limited to, non steroidal anti-inflammatory agents, such as aspirin, ibuprofen, diclofenac, naproxen, benoxaprofen, flurbiprofen, fenoprofen, flubufen, ketoprofen, indoprofen, piroprofen, carprofen, oxaprozin, pramoprofen, muroprofen, trioxaprofen, suprofen, aminoprofen, tiaprofenic acid, fluprofen, bucloxic acid, indomethacin, sulindac, tolmetin, zomepirac, tiopinac, zidometacin, acemetacin, fentiazac, clidanac, oxpinac, mefenamic acid, meclofenamic acid, flufenamic acid, niflumic acid, tolfenamic acid, diflurisal, flufenisal, piroxicam, sudoxicam, isoxicam, and pharmaceutically acceptable salts thereof, and mixtures thereof. Examples of other suitable non opioid analgesics include the following, non limiting, chemical classes of analgesic, antipyretic, nonsteroidal antiinflammatory drugs: salicylic acid derivatives, including aspirin, sodium salicylate, choline magnesium trisalicylate, salsalate, diflunisal, salicylsalicylic acid, sulfasalazine, and olsalazin; para aminophennol derivatives including acetaminophen and phenacetin; indole and indene acetic acids, including indomethacin, sulindac, and etodolac; heteroaryl acetic acids, including tolmetin, diclofenac, and ketorolac; anthranilic acids (fenamates), including mefenamic acid, and meclofenamic acid; enolic acids, including oxicams (piroxicam, tenoxicam), and pyrazolidinediones (phenylbutazone, oxyphenthartazone); alkanones, including nabumetone and Cox-II inhibitors, including rofecoxib and celecoxib.
[0087] The gas releasing material of the present invention can be utilized for different purposes other than to avoid or reduce creation of a vacuum in a packaging system. For example, the gas liberated from the gas releasing material can be utilized as an indicator that the particular package has been exposed to unwanted conditions such as heat or moisture during its storage or distribution. In such embodiments, the liberated gas upon exposure to these conditions could activate an indicator, such as the protrusion of a seal.
[0088] The following examples are set forth to assist in understanding the invention and should not, of course, be construed as specifically limiting the invention described and claimed herein. Such variations of the invention, including the substitution of all equivalents now known or later developed, which would be within the purview of those skilled in the art, and changes in formulation or minor changes in experimental design, are to be considered to fall within the scope of the invention incorporated herein.
EXAMPLE 1 (Prophetic)
[0089] Following the teachings of U.S. Patent No. 4,289,794, 1000 grams of sucrose, lactose and corn syrup in a weight ratio of 52:27:21 are dissolved in water and evaporated at a temperature of 320° F at atmospheric pressure to produce a melt having a moisture content of about 3%. This melt is placed in a pre-heated Parr bomb (a small pressure vessel equipped with a mixer). The bomb is placed in a controlled temperature bath (e.g., between 300 and 400° F) and pressurized with C02 at 750 psig for five minutes during which time the sugar melt is mixed vigorously. Following the carbonation, the pressure is maintained while the vessel is cooled to room temperature as to solidify the sugar melt. Rapidly releasing the pressure, e.g., with a screw valve that releases pressure over about 5 seconds, fractures the solidified carbonated material to produce multiple pieces of various sizes of gas releasing material.
[0090] A sufficient amount of the resultant gas releasing material is incorporated into a sealed container with a pharmaceutical product susceptible to oxidative degradation and an iron based oxygen scavenger.
EXAMPLE 2 (Prophetic)
[0091] Commercially available PopRocks® are obtained and a sufficient amount is incorporated into a sealed container with a pharmaceutical product susceptible to oxidative degradation and an iron based oxygen scavenger.
GENERAL PROCEDURES
[0092] For Examples 1 and 2, the characteristics of the gas releasing material can be measured by subjecting the gas releasing material to a variety of conditions/times and testing for the amount of remaining gas in the material. For example, an amount of gas releasing material can be placed in an open dish in a vacuum oven as a function of:
pressure (0.8 atm -1 atm), temperature (RT- ~60°C), time (1 or 2 days), and %RH (0%-
-100%). The remaining gas in the gas releasing material can be tested against an established baseline. One method to measure the amount of remaining gas is to place the gas releasing material in water to liberate all of the remaining gas and take a
measurement with an apparatus depicted in Figure 1. The baseline can be established using the same procedure.
[0093] Figure 1 shows a container (1) containing a gas releasing material (2) placed in a cup with magnets (3). The container is attached with tubes (4) to a syringe (5) and a pipette (6). The pipette is modified by having the fat end cut and immersed in water. The container is sealed and water is drawn up to a measurement line (7) on the pipette with the syringe. The syringe is detached and the plunger is depressed and decompressed without changing the water level. The cup is rotated from the outside with the magnets and the gas releasing material falls into the water and gas is evolved. The evolved gas will lower the water volume from the measurement line on the pipette. The plunger on the syringe is withdrawn until the water returns to the water level line. The volume on the syringe will represents the volume of gas evolved from the gas releasing material.
[0094] One method to maintain a desired humidity level is to utilize particular saturated salts which maintain specific humidities as a function of temperature. Examples of saturated salts which can be utilized include potassium hydroxide, lithium chloride, potassium acetate, magnesium chloride, potassium carbonate, magnesium nitrate, sodium dichromate, ammonium nitrate, sodium nitrite, sodium chloride, ammonium sulphate, potassium chloride, potassium nitrate, and potassium sulphate. The temperature and humidity can be measured by a temperature/humidity logger.
[0095] Another method to measure the amount of remaining gas and/or to establish a baseline is to use a grab sampling tube that is filled with small granules of a special chemical that has a very high ability to absorb the gas that is being measured. This chemical is called a sorbent. For example, hydrazine hydrate or sodium hydroxide coated silica (e.g., ASCARITE II®) can be used as a sorbent for carbon dioxide.
EXAMPLE 3
Objective:
[0096] To test the ability of a gas releasing material to relieve the partial vacuum in a pharmaceutical package created by a contained 02 scavenger.
Materials:
[0097] - 33-400 C/R click loc caps commercially available from Drug Plastics and Glass Co. (Boyertown, PA.)
- 75 cc HDPE Bottles commercially available from Drug Plastics and Glass Co.
- PopRocks (1) 0.24 oz (6.8 g) Package Watermelon Flavor. The number 1 12 printed on back
- Multisorb DF-100 H42 02 absorbing canisters commercially available from Multisorb Technologies (Buffalo, NY)
- Foil (Aluminum) Strip: 1 inch (2.54 cm) x 3 inches (7.62 cm) cut from 0.024 mm thick sheet
- Lepak Jr. Induction Sealer commercially available from Lepel (Waukesha, WI)
- Marathon Digital Caliper commercially available from Marathon Watch Co., Ltd. (Richmond Hill, Ontario)
[0098] HDPE Bottles were chosen to be 36.3 mm thick (front to back) and 46.6 mm (side to side) and were packaged and labeled in the following configuration:
Bottle 1 : 4 g Pop Rock; 02 absorbing canister; foil strip.
Bottle 2: Empty
Bottle 3: 02 absorbing canister
[0099] All three bottles were induction sealed at 0.70 seconds.
[00100] Approximately six days later (after the above induction sealing), the face to face distance was measured for each bottle. Small magnets (3 mm diameter, 1.5 mm thick) were placed on the jaws of the caliper to enable measurement of the concave faces. The measurements are set forth in Table 1 below:
Table 1
[00101] Bottles 1 and 3 were concave front to back and remained convex side to side Bottle 2 remained convex at all sides. The dimensional changes in the bottles from the initial measurements to the measurements in Table 1 are set forth in Table 2 below:
Table 2
[00102] The difference between Bottle 1 and Bottle 3 indicates that some of the gas was released from the Pop Rocks spontaneously without the necessity to provide an activation step.
[00103] Thereafter, Bottle 1 was placed in an inverted induction sealer. The sealer was set to 2.00 seconds and activated. This was done 4 times for each bottom corner of the bottle. Popping was heard on the first 3 corners, but not the fourth. The popping sound indicates that the induction sealer heated the foil which activated the gas releasing material to release an amount of gas. The system was allowed to cool for about 4 hours and measurements were repeated as set forth in Table 3 below:
Table 3
[00104] After induction, 1.5 mm of the 3.6 mm was regained and 0.2 of the 0.7 mm was regained.
[00105] The present invention is not to be limited in scope by the specific embodiments disclosed in the examples which are intended as illustrations of a few aspects of the invention and any embodiments that are functionally equivalent are within the scope of this invention. Indeed, various modifications of the invention in addition to those shown and described herein will become apparent to those skilled in the art and are intended to fall within the scope of the appended claims.
Claims
1. A packaging system comprising:
a container having an inner cavity;
a gas removing material; and
a gas releasing material.
2. The packaging system of claim 1, further comprising a consumer or industrial product.
3. The packaging system of claim 1 or 2, wherein the gas removing material
comprises an adsorbent, a scavenger, or a combination thereof.
4. The packaged system of claim 3, wherein the gas removing scavenger comprises an oxygen scavenger, a carbon dioxide scavenger or a combination thereof and the adsorbent comprises zeolite, charcoal, silica or a combination thereof.
5. The packaged system of claim 4, wherein the oxygen scavenger is based on iron, catechol, ascorbic acid, oxidative enzymes, unsaturated hydrocarbons or polyamides.
6. The packaging system of any one of claims 1 to 5, wherein the container is
permeable or substantially impermeable to gas.
7. The packaging system of any one of claims 1 to 6, wherein the container is sealed and holds the product, the gas removing material and the gas releasing material in the inner cavity.
8. The packaging system of any one of claims 1 to 7, wherein the container is a bottle, a bag, a vial, an envelope, a canister or ajar.
9. The packaging system of any one of claims 1 to 8, wherein the container has a removable seal.
10. The packaging system of any one of claims 2 to 9, which contains a consumer or industrial product and wherein the product is subject to degradation.
1 1. The packaging system of claim 10, wherein the product is subject to oxidation.
12. The packaging system of claim 10 or 11, wherein the product subject to
degradation is selected from the group consisting of a pharmaceutical, a foodstuff, and a chemical.
13. The packaging system of claim 12, wherein the product is a pharmaceutical.
14. The packaging system of claim 13, wherein the pharmaceutical is an opioid
analgesic.
15. The packaging system of claim 14, wherein the opioid analgesic is selected from the group consisting of codeine, hydromorphone, hydrocodone, oxycodone, dihydrocodeine, dihydromorphine, morphine, tramadol, oxymorphone, pharmaceutically acceptable salts thereof, and mixtures thereof.
16. The packaging system of claim 15, wherein the opioid analgesic is oxycodone or a pharmaceutically acceptable salt thereof.
17. The packaging system of any one of claims 1 to 16, wherein the gas releasing material contains compressed gas.
18. The packaging system of claim 17, wherein at least a portion of the compressed gas is in liquid form, solid form or a combination thereof.
19. The packaging system of any one of claims 1 to 18, wherein the gas releasing material contains from about 0.5 ml to about 25 ml gas per gram of material.
20. The packaging system of any one of claims 1 to 19, wherein the gas contained in the gas releasing material is selected from the group consisting of nitrogen, carbon dioxide, inert gases, air and a combination thereof.
21. The packaging system of any one of claims 1 to 20, wherein the gas releasing material liberates gas upon activation.
22. The packaging system of claim 21, wherein the activation is by an external or internal heat source.
23. The packaging system of claim 21 or 22, wherein the activation method
comprises pressure change, temperature change, moisture change, magnetic field change, electromagnetic radiation or a combination thereof.
24. The packaging system of claim 23, wherein the electromagnetic radiation
comprises visual light, ultraviolet radiation, microwave radiation, IR radiation and induction fields.
25. The packaging system of any one of claims 1 to 24, wherein the gas releasing material liberates gas at a temperature below the melting point of the material.
26. The packaging system of any of claims 1 to 20, wherein the gas releasing material liberates gas spontaneously over time.
27. The packaging system of any one of claims 1 to 26, wherein the gas releasing material comprises a carbohydrate.
28. The packaging system of any one of claims 1 to 26, wherein the gas releasing material comprises a material selected from the group consisting of a saccharide, a sugar alcohol, a starch, a dextrin, a gelatin, a gum, a protein and a combination thereof.
29. The packaging system of claim 28, wherein the saccharide is selected from the group consisting of a monosaccharide, a disaccharide, an oligosaccharide, a polysaccharide and a combination thereof.
30. The packaging system of claim 29, wherein the polysaccharide is chitosan.
31. The packaging system of claim 28, wherein the gum is selected from the group consisting of agar, carrageenan, alginate, pectin, xanthan, locust bean, guar and combinations thereof.
32. The packaging system of any one of claims 1 to 31, which contains an oxygen scavenger in an effective amount to remove oxygen from the sealed container.
33. The packaging system of claim 32, wherein the gas releasing material is capable of liberating an effective amount of gas to replace at least a portion of the oxygen removed by the oxygen scavenger.
34. The packaging system of any one of claims 1 to 33, wherein the gas releasing material has desiccant properties.
35. The packaging system of any one of claims 1 to 34, further comprising a
susceptor.
36. A method of packaging a product subject to degradation comprising:
including a gas releasing material in a container with (i) the product subject to degradation and (ii) a gas removing material.
37. The method of claim 36, further comprising sealing the container.
38. The method of claim 36 or 37, wherein the container is permeable or substantially impermeable to gas.
39. The method of any one of claims 36 to 38, wherein the product is subject to
oxidation.
40. The method of any one of claims 36 to 39, wherein the product subject to
degradation is selected from the group consisting of a pharmaceutical, a foodstuff and a chemical.
41. The method of any one of claims 36 to 40, wherein the product is a
pharmaceutical.
42. The method of claim 41, wherein the pharmaceutical is an opioid analgesic.
43. The method of claim 42, wherein the opioid analgesic is selected from the group consisting of codeine, hydromorphone, hydrocodone, oxycodone, dihydrocodeine, dihydromorphine, morphine, tramadol, oxymorphone, pharmaceutically acceptable salts thereof, and mixtures thereof.
44. The method of claim 42 or 43, wherein the opioid analgesic is oxycodone or a pharmaceutically acceptable salt thereof.
45. The method of any one of claims 36 to 44, wherein the gas removing material comprises an adsorbent, a scavenger or a combination thereof.
46. The method of any one of claims 36 to 45, wherein the gas releasing material contains compressed gas.
47. The method of any one of claims 36 to 46, wherein the gas releasing material contains from about 0.5 ml to about 25 ml gas per gram of material.
48. The method of any one of claims 36 to 47, wherein the gas contained in the gas releasing material is selected from the group consisting of nitrogen, carbon dioxide, inert gases, air and a combination thereof.
49. The method of any one of claims 36 to 48, wherein the gas releasing material liberates gas upon activation or spontaneously over time.
50. A device comprising:
a housing having at least one internal compartment in fluid communication with the exterior of the housing;
a gas removing material; and
a gas releasing material.
51. The device of claim 50, wherein the gas removing material and the gas releasing material are contained in the same internal compartment.
52. The device of claim 50 or 51 , wherein the gas removing material and the gas releasing material are at least partially interdispersed.
53. The device of any one of claims 50 to 52, wherein the gas removing material and the gas releasing material are contained in different internal compartments.
54. The device of any one of claims 50 to 53, wherein the gas releasing material contains compressed gas.
55. The device of any one of claims 50 to 54, wherein the gas releasing material contains from about 0.5 ml to about 25 ml gas per gram of material.
56. The device of any one of claims 50 to 55, wherein the housing comprises a material selected from the group consisting of plastic, paper, fabric and metal.
57. The device of any one of claims 50 to 56, wherein the housing comprises a sachet.
58. The device of claim 57, wherein the sachet comprises the gas releasing material and/or the gas removing material.
59. Use of a gas releasing material to suppress or reduce a vacuum in a container.
60. The use of claim 59, wherein the vacuum in the container is caused by the
presence of a gas removing material in the container.
61. A packaging system comprising:
a container having an inner cavity;
a consumer or industrial product; and
a gas releasing material.
62. The packaging system of claim 61, wherein the product is a pharmaceutical.
63. A method of packaging a product subject to degradation comprising:
including a gas releasing material in a container with a product subject to degradation.
64. The method of claim 63, wherein the product is a pharmaceutical.
65. A method of increasing the stability of a consumer or industrial product
comprising preparing a packaging system according to any of claims 1-35, 61 or 62.
66. A method of decreasing package failure comprising preparing a packaging system according to any of claims 1-35, 61 or 62.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/817,334 US20130240384A1 (en) | 2010-08-18 | 2011-08-17 | Vacuum Avoiding Packaging Systems and Methods Thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37464910P | 2010-08-18 | 2010-08-18 | |
US61/374,649 | 2010-08-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012023030A2 true WO2012023030A2 (en) | 2012-02-23 |
WO2012023030A3 WO2012023030A3 (en) | 2012-04-12 |
Family
ID=44789514
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2011/001901 WO2012023030A2 (en) | 2010-08-18 | 2011-08-17 | Vacuum avoiding packaging systems and methods thereof |
Country Status (2)
Country | Link |
---|---|
US (1) | US20130240384A1 (en) |
WO (1) | WO2012023030A2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014051963A1 (en) * | 2012-09-28 | 2014-04-03 | Pepsico, Inc. | Use of adsorber material to relieve vacuum in sealed container caused by cooling of heated contents |
WO2019209340A1 (en) * | 2018-04-27 | 2019-10-31 | Hewlett-Packard Development Company, L.P. | Containers with gas vessel |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3012893A (en) | 1959-01-06 | 1961-12-12 | Gen Foods Corp | Gasified confection and method of making the same |
US4001457A (en) | 1976-07-01 | 1977-01-04 | General Foods Corporation | Method of making a gasified confection |
US4289794A (en) | 1980-03-12 | 1981-09-15 | General Foods Corporation | Process of preparing gasified candy |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6269945B1 (en) * | 1998-10-29 | 2001-08-07 | Tres Fresh Llc | Packaging system for preserving perishable items |
DE50015885D1 (en) * | 1999-06-09 | 2010-04-22 | Procter & Gamble | Instant gel preparation and use of solid, gasified particles as an acoustic indicator |
EA009623B1 (en) * | 2003-04-30 | 2008-02-28 | Пэдью Фарма Л.П. | Tamper-resistant transdermal dosage form |
CA2659122C (en) * | 2006-08-04 | 2016-08-23 | Ethypharm | Granule and orally disintegrating tablet comprising oxycodone |
US20110127269A1 (en) * | 2008-05-15 | 2011-06-02 | Michael Bucholtz | Vial with non-round seal |
-
2011
- 2011-08-17 WO PCT/IB2011/001901 patent/WO2012023030A2/en active Application Filing
- 2011-08-17 US US13/817,334 patent/US20130240384A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3012893A (en) | 1959-01-06 | 1961-12-12 | Gen Foods Corp | Gasified confection and method of making the same |
US4001457A (en) | 1976-07-01 | 1977-01-04 | General Foods Corporation | Method of making a gasified confection |
US4289794A (en) | 1980-03-12 | 1981-09-15 | General Foods Corporation | Process of preparing gasified candy |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014051963A1 (en) * | 2012-09-28 | 2014-04-03 | Pepsico, Inc. | Use of adsorber material to relieve vacuum in sealed container caused by cooling of heated contents |
CN104853998A (en) * | 2012-09-28 | 2015-08-19 | 百事可乐公司 | Use of adsorber material to relieve vacuum in sealed container caused by cooling of heated contents |
JP2015536878A (en) * | 2012-09-28 | 2015-12-24 | ペプシコ, インコーポレイテッドPepsiCo Inc. | Use of adsorbent materials to relieve the vacuum in sealed containers caused by cooling of heated contents |
EP2909106A4 (en) * | 2012-09-28 | 2016-08-03 | Pepsico Inc | USE OF AN ADSORBENT MATERIAL FOR RELIEVING THE VACUUM IN A SEALED CONTAINER CAUSED BY COOLING HEATED CONTENT |
US9481503B2 (en) | 2012-09-28 | 2016-11-01 | Pepsico, Inc. | Use of adsorber material to relieve vacuum in sealed container caused by cooling of heated contents |
AU2013324129B2 (en) * | 2012-09-28 | 2016-11-03 | Pepsico, Inc. | Use of adsorber material to relieve vacuum in sealed container caused by cooling of heated contents |
CN104853998B (en) * | 2012-09-28 | 2016-11-09 | 百事可乐公司 | For cutting down the use of the sorbent material sealing the vacuum being caused in container by the cooling of hot content |
WO2019209340A1 (en) * | 2018-04-27 | 2019-10-31 | Hewlett-Packard Development Company, L.P. | Containers with gas vessel |
US11868083B2 (en) | 2018-04-27 | 2024-01-09 | Hewlett-Packard Development Company, L.P. | Containers with gas vessel |
Also Published As
Publication number | Publication date |
---|---|
US20130240384A1 (en) | 2013-09-19 |
WO2012023030A3 (en) | 2012-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8449920B2 (en) | Sustained release beads and suspensions including the same for sustained delivery of active ingredients | |
CA2520600A1 (en) | High-intensity sweetener composition and delivery of same | |
CN103153452A (en) | Oxygen absorber and method for storing same | |
RU2385624C2 (en) | Packed concentrate for cooking broth, soup, gravy, and sauce or for using as seasoning containing xanthan or cussia gum, procedure for its production and application | |
AU2010202518A1 (en) | Process for preparing bakeable probiotic food | |
GB2111423A (en) | Moulding quick-dissolving dosage units | |
CN109362950B (en) | Rumen-protected choline chloride microcapsule and preparation method thereof | |
US20130240384A1 (en) | Vacuum Avoiding Packaging Systems and Methods Thereof | |
CN115297945A (en) | Oxygen scavenger composition | |
US20060280843A1 (en) | Filler for a beverage container | |
WO2005092124A1 (en) | Process for producing health food containing dietary fiber | |
CA3026138C (en) | An edible composition for reducing the digestion or absorption of the harmful/toxic substance | |
CN101658482A (en) | Low molecular chondroitin sulfate oral preparation, preparation method thereof and use thereof | |
AU2014203766A1 (en) | Pack of medicinal tablets | |
US20240366659A1 (en) | Activated Carbon for Detoxification of Intoxications, Including Methods of Use Thereof | |
CN1515471A (en) | Room temp. storage method of product containing anaerobic formers and product packaged by adopting said method | |
JP3247632U (en) | Probiotic Pack Combination for Gut Health | |
JP2019108301A (en) | Method for producing HMBCa-containing granules, and supplement | |
JPS59213440A (en) | Tableted deoxidizing agent | |
CN117296925A (en) | Metazoan milk-based nutritional composition and preparation method thereof | |
JP5615522B2 (en) | Solid pharmaceutical composition | |
JP5821247B2 (en) | Method for inhibiting sublimation of ibuprofen | |
WO2008037577A1 (en) | Process for production of compounds, which are starch containing particles coated, embedded or encapsulated by at least one biopolymer | |
US20170127711A1 (en) | Packaged food product and method | |
JP2004075582A (en) | Method for stabilizing ingredient other than active ingredient prescribed in solid pharmaceutical composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11768093 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13817334 Country of ref document: US |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 11768093 Country of ref document: EP Kind code of ref document: A2 |